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The "Human World Population''., that is, the number of hands avail-
able for work and the number of mouths to. feed is the basic determi-
nant of economic activity. However, world prosperity depends not only 
on the number of people alive at any given time but also on how effi-
ciently they work and how much income they have to spend. It is people 
who produce and consume, build and destroy, . procreate and die. More-
over, it is the wisdom and efficiency with which they carry out these 
activities that keeps the world's economic machinery running and thus 
maintains high standards of living in sophisticated societies. 
During mo.st of man's existence on earth, high fertility was 
necessary if the race was to survive. Throughout_the world prior to 
1600 AD, population never grew faster than 0.3 percent per year except 
where virgin land was being settled •. The growth rate did not exceed 
0.5 percent a year until after 1800 AD. 
Prior to World War II, life expectancy for people living in the 
underdeveloped countries was.low and parents who.wanted to be assured 
of having children to care for them in their old age attempted to 
raise large families. 
· Following World War.II, technological developments of Europe and 
North America were introduced on a.large scale into the world's more. 
backward.regions. Techniques for improving public health were widely 
adepted. Life expectancies in some ,areas. of the underdevele:>ped world 
have increased to a level enly moderately below that of the United. 
States thus high death rates.no longer,cancel out high birth rates. 
The dimensions ef the pepulation preblem today are of great mag-
nitude. Half e:>f the world's present population has been bern since 
2 
the end.ef Werld War II. The present pepulation growth rate is almost 
2 percent per year, aqding apprCi>ximately 70 million people each year. 
This means adding another New York City to the world's population every 
6 weeks. 
If the-population ,growth is allowed te continue unabated, the 
prime concern will be enough food to sustain human life. Considering 
the current level ef agricultural technicelogy food.supplies may be 
maintained to support the world popul;at·ion until the year 2025 A.D. 
Beiond :this date.the outloqk is bleak. 
CHAPTER II 
REVIEW OF LITERATURE 
Intreduction 
Overpca>pulation is the greatest·pr<:>blem facing mankind tca>day. 
Population gr<:>wth in the United States emerged·as a prominent concern 
with urban and environmental deteriorations in the United States and 
with increased world population pressures. 
Systemic methods of contraception have been developed for the 
female. However, very little effort.has been expended in the de-
velopment of systemic contraceptive measures in the male. 
Spermatogenesis is a lengthy process of cell division and·matu-
ratio:r:i resulting inthe formation of spermatoz0a. This process is 
inter:r;-upted by exposure to heat, irradiation, cadmium, immunologic. 
factors, certain chemical agents and·some gonadal hormones. However, 
most of .these factors.cannot be used as effective contraceptive 
measures because of irreversible changes.in the germinal epithelium 
or because of deleterious side effects. The simplest method of in-
hibiting spermatogenesis with the minimum ef deleterious side effects 
might involve intereference with pituitary regulation of testosterone 
secretic,m by the interstitial cells of Leydig. However, questions 
such as: what ho:r;-mcmal faqtors regulate the production of spennatozoa 
by the germinal epithelium and what factors are known to inhibit 
spermatG>genesis remain to be answered. 
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The Regulation of Spermatogenesis 
The seminiferous tubules ef·the testis are lined with an epi-
thelium.from which spermatozoa are proliferated. Spermat0gonia 
lying next to the basement membrane, undergo a .series of mitotic 
divisic.ms. leading t0 the·. formation of prima:t;"y spermatocytes. These 
undergo the first meiotic divisic,n and· give rise to cells called 
secondary spermatocytes. The latter begin the second meiotic divi-
sion almost immediately and produce smaller haploid cell$ which are 
called spermatids. The process of transformation of spermatogonia 
to spermatids, ready te be released into the lumen of the semini-
ferous tubule, is called spermatogenesis. 
The germinal epithelium carries out t~ree principal processes: 
1). increase in number of cells by mit0sis, 2) reduction. in the number 
of chromosomes by m~iosis, and 3) the production. of testicular sper-
matozoa from spermatids br spermiege:nesis. 
Although it is known that complete spermatogenesis requires 
specific hormones, the endocrine regulation of the germinal epithe-
lium is complex .and general aggreement has not been reached regarding 
the nature of the hormones required (Hall, 1970). 
Influence ef Hypophysectomy cm Spermatogenesis 
Spermatogenesis fa.ils in the hypophysectomized animal. 0r man 
(Greep and Fevold; 1937) (Lipsett et aL, 1956) • A number of inves-
tigators (Smith, 1927) (Greep a:r:id Fevold, 1937) (Woods. and Simpson, 
1961) (Los:troh, 1963) realized that pituitary ablation caused gonadal 
I 
atrophy~ ~aiN~ver, difficultt ~as encountered in attempts to separate 
the effect ef damctge inflicted by the ablation procedure to the 
pituitary, hyJ;>othalamus; al'l.d adjacent brain tissue. Smith's (1927, 
1930) classical experiments demonstr~ted atrophy of the testes and 
cessation of spermatogenesis in male rats following hypophysectomy. 
Moreover he showed that the pronounced atrophy of the testes, and 
accessory sex organs wa$ restored to near control levels by daily 
admini_strc;l. tion of an ter,j,.or pituitary extract. 
Extensive investigations (Greep et al., 1936, 1937) in succeeding 
years confirmed Smith's observations, and led to the hypothesis that 
pituitary gonadot:rophic factort;1 may play specific roles in maintaining 
testis function. This hypothesis was widely accepted and led to the 
concept·follicle·stimulating hormone. (FSH) controlled the spermato-
genicprocess and leutinizing hormone (LH) controlled testosterone 
production by Leydig cells. 
Greep's formulation of the above concept resulted from using 
crude preparations of FSH and LH and thus is suspect. 
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Woods and Simpson (1961) an __ d · Lostrob (1963) have questioned the 
exact role of FSH·and LH in regulating testis function. Administration. 
of anterior pituitary extracts to hypophysectomized rats will restore 
and maintain spermatogenesis, (Smith, 1936) (Woods and Simpson, 1961). 
Similarly, ICSH, (Simpson et al., 1944) or androgens, (Nelson and 
Gallagher, 1936) have·been shown to maintain spermatogenesis in hypo-
physectomized: animals. The cor1eept that· FSH maintains germinal epi the-
lium and ICSH stimulates the Leydig cells .has been challenged by Lostroh 
et.al~, (1963). Lostroh's group reported repair of the germinal epi-
thelium in hypophysectomized rats given ovine .FSH plus one milligram or 
less of ICSH per day, but copcomittant treatment with antiserum to ICSH 
prevented spermatid formation. The authors concluded that FSH may play 
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a _role ._in the fcrmatic;m of· spermatogonia and primary spe:rmatccytes, but 
suggest that the formation of spermatids requires both hormones. 
Steinberger and Duqkett, (1965) injected male rats with estradiol 
benzoate or te.stosterone propionate daily fr0m birth. The weight of 
testes from animals receiving estrogen for-periods up to two months was 
suppressed. No increase.above that found in normal-thirty day old, pre-
puberal ·animals was.found. The first wave of spe:rmatogenesis commenced 
at the expected time, but proceeded only to the stage of pachytene pri-
mary spe:rmatocytes. In no case was completion of·the mei0tic division 
observed. 
Weight of testes from testosterone treated animals was suppressed, 
but to considerably less extent than that.of estrogen treated animals. 
Spermat(l)genesis in the testosterone treated.animals commenced at the 
expected time and proceeded normally up t0 primary spermatocytes., but 
spermatid appearance was significantly delayed and complete maturation 
did not occur, even.in animals three months.of age. This work suggests 
spermatogenesis can.commence in rats receiving doses.of estrcgen or 
testoste:rcme which inhibit pituitary gonadotrophins (Ludwig, 1950), but 
will .not proceed to mature spermatozoa. Confusing results reported on 
restoration of spe~matogenesis in hypophysectomized animals by testos-
te.rone may be cont:riputed t0, by: l)s incomplete hypophysectomy, · allowing 
a low output.of pituitary gonadotrophins in some animals. This con-
stituted up to 25 percent of ·the experimental anii;nals in one study re-,, 
ported by Lostroh (1963); 2) time elapsing from hypophysectomy and 
initiation of replacement· therapy; and 3) age 0f the animals used in 
the experiments. 
Although the exact·roles played by FSH and LH in mammalian 
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spermatogenesis are confused, ·there is little doubt that these gonado-
trophins are necessary for complete spermatogenesis to occur. It is 
suspected that prolactin and growth hormone.may play important roles in 
spermatogenesis~ Growth hormone.administe.red simultaneously with ICSH 
enh~nced androgen.secretion in hypophysectomized rats·as evidenced by 
increased testicular and prostate gland·weights in rats (Woods and 
Simpson, 1961) (Lostroh. et al., 1958). Growth hormone administered 
simultaneously with FSH and testosterone increased the te9ticular weight 
57 percent over that Gbtained with FSHand testosterone (Lostrob, 1969). 
Hypophysectomized rats receiving ICSH; growth hormone, and prolactin 
showed large:i;: increases in testis weight·than animals receiving ICSH. 
and growth hormone, However, ICSH plus prolactin treatment did not in-
crease·testicular weight -as much as ICSH plus growth hormone. These 
latter results suggest that growth hormone permits prolactin to exert 
an action ori. the testis. Thus it appears·that several trophic.hormones 
from the pituitary .are involved in the regulation of spermatogenesis. 
Influence of Testosterqne Upon;;Spermatogenesis 
The male SE::?X hormone, testosterone, is synthesized and secreted by 
the . intersititial cells of ·_Leydig which are. interspersed among the semi-
niferous tubules. Christensen and Mason (19~5) have.shown that most 
testosterone pr0duced within a .testis is. from the interstid,al tissue, 
with only a small.amount being produced by1he seminiferous tubules. 
The effect of testosterc.me on spermatogenesis has been elucidated 
by experiments testing: 1) the effect of testosterone in hypophysec-
tomized animals, 2) the effect of testoster.one. in· animals wi t4 impaired 
release of pituitary gonadotrophins and 3) the effect 0f test0sterone 
on ~e ·hypothalamus. 
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Effec'I;. of testos.terone in Hypophysectomize.d Animals. The ability 
of testesterene tom~intain er initiate and.maintain spermatogenesis in 
hypophysectomized animals. has been stud.i,ed by many investigators. Ha-
milton and Le(.;)nard (1938) reported that daily injectins of;SOO ]Jg of· 
testosterone propionate (TP) initiated immediately after hypophysectomy 
resulted in scrotal.testes that were ninety-four percent heavier than 
those. in untreated hypophysectomized. contra>! ra.ts. Histological. exami-
nation .of control testes revealed that there were.few or ne spermatozoa 
altheugh ·spermatids were present in the seminifereus. tubules. The· 
seminiferous tubules in the hypophysectom.i,zed:rats receiving TP tr.eat-, 
ment daily for six.weeks following surgery were well develeped,. but· 
spermatids tended to clump and.miteses were fewer,in number. WheJ:?-. the 
in:itiation ·of :TP treatment was delayed nine t0 fifty-ene · days after 
hype>physecitamy, well develeped tubules were never ebserved. · 
Woods and Simpson (1961) repGrt,ed no maintenance of spermatogenesis 
in male rats hypophysectomized·at forty days of age.and treated with 
10 ]Jg testoster0ne propionate (TP). daily for fifteen days. HG>wever, in 
the .. same animal mt>del, 50 µg, TP· daily for fifteen. days produced sperma-
tids in forty percent of the rats tested. 
Weod_s and SimpsC:>n (1961) also reperted Gm the ability ·Of testos-
terone to repair the.spermategenic process in-rats hypophysectomized at 
forty days ef:age with initiatien of TP treij.tment de],ayed fourteen days 
past hypophysectomy. Three levels of the horma>nal steroid (10, SO, artd 
250 µg per.day) were given to three groups of .rats.for twenty-eight 
days. · 0nly the animals receiving th~ 250 ]Jg per day dosage of . TP pro-
duc.ed ctny sperinatids. Moreover, the 250 µg TP daily returned: .testicular 
weights to only twenty-two perea:ent ef normalunoperated rats the same 
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age; while increasing the weights ef the ventral prostate.and seminal· 
ves.icles 260 percent and 665 percent above normal; respectively. These 
results suggest that tlie level of testosterQne needed for maintenance 
of the germinal.epithelium is much higher than the level needed·for 
maintenance ef accessory sex organs. 
Ludwig (1950) reported the results of experiments testing the 
effect ef , testosterc:me. on the seminiferous epithelium of rats hypophy-:-
sectc::,mized at thirty days (;)f age. 0ne.testis was removed at the time 
ef hypof)hysectomy and the other.removed following thirty days of TP 
administration (l.·O mg/day). Histological .examination of testes re-
moved at the time-ef hypophysectomy.(thirty days of age) revealed early 
spermatids predeminating in the tubules. Seminiferous tubules of 
hypo]?hysectomized, ccmtrols at sixty days of age. showed a ma;i:-ked de-
crease· in diameter.and degeneration of the germinal epithelium to 
spermatogonia and spermatocytes. Fifty percent Gf the animal.s · re-, 
ceiving 1.0 mg TP·daily, post-hypophysec'l;:omy, to sixty days.of age 
maintained semin,tferous tubule size and some tubules contained·• sperma-
tids and spermatozcia. 
Boccabella (1963) reported reinitiation and restoration of sperma-:-
togenesis with TP after a long-term posthypophysectomy period. Treat-
ment of hypCl>physectomized male rats with 3 mg per day of _TP initiated 
65 aays after surgery and contineud for 90 to 110 days, restored sper-
matogenesis in approximately 33 percent of the animals tested. 
The studies reviewed above utilized hypophysectomized anima],s~ 
The replacement the:i:;-apy was initiated immediately or delayed allowing. 
the germinal epitheliuil'\ to degenerate. There ar.e obvieus preblems with 
the hypophysectomized, animal mQdel including: 1) incomplete removal. of 
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all gonadotrophin producing tissue (Lostroh, 1963); 2) unfavorable in-
ternal environment·resulting from the removal of the trophic herrnones 
regulating the functions of other endocrine glands, and 3) the.loss of 
sensitivity of the.testis te> exogenously administered hormones, depen-
ding upon the time of initiation of treatment following hypophysectomy. 
In ·light of the above reservations, ether experimental approaches have 
been used. to determine .the effect 0f testos.terone upon sperrnategenesis. 
Effect.of Teste>sterone .i:n AnimaJ.s·.i:n Which the Secretion of 
Pituitary Gcmadotrophins: Has Been Inhibited. Steinberger and Duckett 
(1965) investigated hormonal requirements for the initiation of sper~ 
matogenesis in newl::lorn rats and studied the .factors required f0r its 
completion.· They demc.>nstrated that daily administration of estradiol 
benzoate from birth, in_deses that suppress pituitary gonadotrephins 
te> ·undetectable levels, does net prevent initiation of the sperrnato-
genic process. The first wave ef spermatogenesis proceeds te th,e stage 
of late pachytene spermatocytes. Continued estradiol treatment results 
in.the failure ef.subsequent waves of sperrnatocytes to form. Stein-
berger, and.Duckett (1967) rep0rted results of the administration of 
testostere>ne te 15 day old rats receiving estradiol daily from birth. 
Testoster.ene injections were started (2 mg per day) at 15 days ef age 
thus the animals re.ceived both testosterone and estradiol from 15 te 65 
days of age. Althol,l.gh the mean testicular weight·at.60 days ef .age was 
far below that·of .normal 60 day eld animals the .mean testicular weight 
was 580 percent greater than that of rats receiving no testostere>ne 
therapy. Spermatogenesis preceeded to midpeint in most seminiferous 
tubules and the prostate·and seminal vesicles were stimulated. 
Karla and Prasao. (1967) reported that daily adrninistr.ation of .. 
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clomiphene (1- p (beta-diethylaminaeth0xy-phenyl ..... 1, 2-diphenyl-2-
chloroethylene) tG immature rats beginning Gn day 22, caused an arrest 
of spermatogenesis at the primary spermatocyte stage. Two hundred 
micrograms of testosterGne propionate.administered daily frem day thirty, 
to clomiphene-fed rats, advanced spermat0genesis from the primary sper-
matocyte stage, present at. initiation ef TP treatment, te the spermatid 
stage (step 1-7). These data were interpreted to mean that TP exerts 
a stimulatery acticm en .the early phase of spermatogenesis. Admini-
stration of O. 5 to 1. 0 mg per day of Tl? to cl0miphene fed rats re.sul ted 
in the occurrence of.mature spermatozea in the seminiferous tubules sug-
gesting that high doses e:>f testosterone propionate facilitates the ad.-
vance of spermatogenesis from the primary spermatocyte stage to mature 
spermatozoa in . the absence of gc;madotrGphic hQrmones. 
Effect of Testosterone' en the Hypethalamus. Davicl.son (1967), 
reviewed hypothalamic control of testosterone secretion a:i:i.d spermato-
genesis in testis. He concluded the integrity of the hypothalamic 
median ,eminence is essential for maintenance of spermatogenesis by. 
pituitary hormones. Thi.s region appears to contain the receptors. sen-
sitive to changes in circ;::ulating testosteronelevels, since implanta-
tien of crystalline testosterone into this region, but not in the 
pituitary, results in testicular atrqphy in dGgs anq. rats. More evi-
dence for hypothalamic im,olvement in spermategenesis was provided by 
an experiment utilizing hypophysectomized rats with pituitary trans-
plants in the kidney. A small.percentage of the rats so treated showed 
active spermatogenesis and normal testicular weight. Implantation of 
testosterone inte the hypethalamic median eminence Gf these rats pre.., 
duced .· marked testicular inveluticm. 
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Receptors sensitive te> decreased levels ef-testosterone reside in· 
the hypothalamus (Da~idson, 1967). Cypreterone, (1,2 alpha-methylene-
6-chlere-delta 6-17 alpha-hydrexyprogesterone) was shewn to block the 
action of testosterene en the reproductive system and to prevent di·f-
ferentiatien of the male pattern ef genadotrophin secret.i,on by neenatal 
androgen in the rat. Cypreterene implants in the median .eminence. re-
sulted irt a significant stirnulatien ef testes, seminal vesicles, and 
ventral prostates of irnrna.ture (thirty day Old) rats. These findings 
reported by Davidson suggest that an .increased secretion of gonado-
trophin eccurs when testesterone is prevented frem interacting with a 
receptGr in the basal hypothalamic regien. 
Bolt, (1971) reported that a single int:i::amuscular injectic,m of 5 mg 
ef tes-testerone in oil resulted in a marked depression ef plasma cGn-
centration of leutinizing he~one (LH) over a span of fifty-three hours 
in rams.· The mean concentration -of plasma LH over the fifty-three .hour 
test period was 2. 3 ng/ml for control rams cGmpared to O. 78 ng/ml .· fer 
the rams receiving a testosterone injection. 
These experiments conclusively demonstrate that testosterene levels 
in the peripheral circulatien influence the basal hypethalamic region 
to govern the release of releasing factors which .in turn influence the 
outflow of gGnad@,trephins from the. anter ;i.er ,pituitary glal;ld. 
CGnfusion exists as tG the exact role Gf specific hormenal agents 
in the maintenance Gf .spermatogenesis. However, it seems clear that 
gonad<::>trephins and testosterone are necessary fGr complete spermato-
genesis. Test0sterone has at least twe target sites, the direct.action 
on the seminiferCii>us tul:>ules to .suppert sperrnatogenesis and sn the hy-
psthalamus sf the brain ts regulate releasing factc.,r concentration in 
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hypophyseal~portal vessels thus regulating anterior pituitary gonado-
trophi.n prGduct.ien. Thus it appears that any chemical agent ·inter-
fering wit;h gonadotrophin stim4lated testosterone production by Leydig 
cells would result-in cessatien of spermategenesis. The question 
remains however whether some chemical·or physical-agent exhibition 
antispermatogenic characteristi.cs might. be a more effective male c<:>n-
traceptive. 
Factors Inhibiting Spermategenesis 
Inhibition of the spermatogenic process presents a pr<:>mising ap-
proach to the problem of populatic:m control in man.. Hewever, attempts 
to interrupt normal bedy processes such as spermatogenesis are fraught 
with deleterious side effects. 
Several specific criteria fer an antisper.matGgenic agent mi+st be 
met before it could.be considered an effective systemic contraceptive· 
for men: 1) such an agent must be one hundred percent effective;-
2) the effects of the agent must be fully reversible; 3) the agent must· 
not prGduce eff-ects deleterious to the recipient or to future offspring 
of the recipient; and 4) there must be a simple methed for chronic 
administration of a readily available, economically produced material. 
The following sectiGms censider immunelogic reactions, temperature, 
irradiation, cadmium, chemicals, and steroids as inhibitors of sperma-
togenesis and·censequently as potential male centraceptive agents. 
ImmunelGgic Inhibition of Spermatogenesis 
Fre.und et al., (1954) provided the first de.mcmstratiGms of germ 
cell-specific immune-induced aspermatogenesis. A mixture of tissue 
hom0genates of testes emulsified .in Freund-cemplete adjuvant injected 
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inte·adult males ef:the· same s~ecies (guinea pig or-rat) consistently 
gave rise 'to pa:i:;-tial or complete destructien of hest germinal epithe-
lium within six:te eight weeks. 
Mild reactiofl.S are evidenced by shedding ef spermatozoa, ·sper-
ma.tid~ and .spermatocytes in few or,many seminiferous. tubules while 
severe ·1esions result in the-desquamation ef·all germ cells including 
spe:rmategonia. .Freund·,5- aL, emphasized that aspermategenesis could 
be due to· testicular lesions brought en by ac;ijuvant aaministration 
alene. 
Tala.at and ,Laurence (1971), reported impairment of spermategenesis · 
after active.immunization.with leutinizing hormone (LH) in the adult 
male rat and. rabbit; •... Bovine. Lff·,was, .. dissolved in saline and mixed with 
an equal:. volume ef complete. :Freund '.s. adjuvant antige·n emulsion. This. 
was.:foll'i)wed-·;ene, .. week .. later by.:three intraperitoneql injections .of 0.5 
mg ef LH in_0.5 ml saline .administered.at three day intervals. A poel 
of .antisera with .a ,high ... titer .. was·obtained frem actively immunized male 
rabbits and.·used .. in. the animals; for::passive immunization. Active im-
m1i1ni.zation e.f adult .. male rabbits .. and adult male rats with bevine LH 
resulted .. .in .. an .in:t.~rupt..i<im ,ef ;the. ,spe:rmatogenic process of both species 
as evidenced :.by .. the pres.enae, of .cmJ.y. spe:rmategqnia or· spermatocytes in 
the .tubules .ef .. the._an.imals .so. ·treated. th:Lr:t;:y-five days prior .to testes 
remev.al ...... Mereov..er, .. theJ;:e .. waa .. a.:loss.:ef libido in both· species. · 
. . Immunel_ogic .preaecliures, .. \aJ.though. capable- of inhibiting spermato-
.genesis .. ai;e .not .desirable ... methods~-~- .. 'l'he. non-specific action from 
all.e_J:igi.:c; .aspemnatege:nesis,.,reported .. ,by- Freund and the loss ef libido 
following, :immun~zat,ion, w.tth,·LH -limit, ,:bheir usefulness as a male cen-:-
. traoepti ve . 
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Spermategenic Inhibitien· by Increas.ed 'Temperat;.ure 
In species with scrotal testes, spermatogenesis may be-. affected. 
not only by factors which affect whole body-heat, but also by heat·ap-
plied directly to.the scrotum, insulation of the scrotum or even con-
finement of the testis to . the body cavity as occurs in crypto,rchidism. 
Body temperature changes were not as effective in raising th~·tempera-
ture of the testis as was the application of local heat according to. 
Ha~rison·and Harris, (1956). 
The effect of heat on testicular function in mammals seems to 
be similar regardless of the source or means of heat application. 
Marked degeneration of the guinea pig testis occurs following appli-
caticm -of water at 46 to 47 degrees centigrade to the scretum for 
15 te 30 minutes. The degeneration was complete in 12 days and the 
regenerative period required approximately 45 days in some tul:;lules 
(Young, 1927). Bowler.(1967) found that rat testes exposed to water 
at 43.5 degrees centigrade for twenty minutes degenerated.and re-
quired 52 to 65 days to recover from a single application. One heat 
treatment ebviously re,duces th~ germinal epithelium to stem cell 
spermatogonia since the duration of spermatogenesis in th-e rat is 52 
days (C:lerment-and Harvey, 1965). 
Centinuous high envirenmental temperatures (32.2 to 33.3° C) have 
been shown to result in low semen volume, reduced sperm mobility, de-
creased concentration of spermatszoa and reduced percentage of live 
and normal sperm-in-rabbits {Oloufa et al., 1951). 
Findings similar to those described above in guinea pigs, rats 
and -rabbits have been reported for dogs (Cewles, '1965), bulls (Rhynes, 
1971), rams (Moore and Oslund, 1924), monkey (Venkatachalam and 
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Romanathan, 1962), and man (Rock and Robinson, 1965; Robinson and Rock,· 
1965; Robinson et al, • 19.68) • 
Although increased temperature of the testes seems to.produce 
spermatogenic inhibition which is universal among animals with scrotal 
testes such a means of.spermatogenic inhibition is not desirable as a 
male contraceptive measure since it is extremely difficult to apply 
constant·heating to the scrotum. Moreover, permanent injury to the 
germinal epithelium may result from repeated exposure of testes to 
heat. 
Sperrnatogenic Inhibition by Radiation 
The testis is recognized as one of the most radio-sensitive organs 
of the body as measured by the amount of.radiation energy necessary to 
destroy cells of the germinal epithelial tissue. However, there are 
certain cell types within the testis that are radio-insensitive.· These 
include: spermatogonia, the interstitial cells, cells comprising the. 
tubular wall, and the Sertoli cells. 
Radiation brings about infertility by maturation depletion of 
the cellular elements of the germinal epitheliUil) as the intermediate 
and type B spermatogonia are destr0yed. The sensitivity of.the ger-
minal cells to radiation .is closely correlated with cellular division 
and the stage of individual cell development. Damage of the germinal 
epithelium is directly related to the amount of energy the testis is. 
exposed to while repair is inversely related to the time after radia-
tion (Rugh, 1960). 
A recent investigation by Rugh (1971) , showed that stunting was 
the major anomaly of offspring produced from male mice receiving 1,000 R 
X-rays. Irradiation is not desirable as a method of contraception 
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for male animals, at this time, due to the difficulty of applying the 
treatment, short duration of sterility induced by each irradiation 
treatment, and the potential hazard of genetic damage. 
Spermatogenic Inhibition by Cadmium 
Soluble cadmium salts have a very toxic effect on.male gonads of. 
many mammalian species. A report by Par.izek and Zahor (1956) focused 
attention on the deleterious effects of cadmium on testicular tissue. 
Subcutaneous administration of a single dose (3.6 to 7.2 mg/kg body 
weight) of cadmium chloride brings about a rapid progression in the 
testes of ·.rats and mice leading to necrosis and total destruction. 
World wide interest which emerged from these studies has provided 
more.knowledge on the ef:l;ects of cadmium on the testis than any other 
element. 
Injurious effects of cadmium are often considered selective; 
since the administration of a dose as low as 1.8 to 3.6 mg/kg body 
weight provokes or induces morphological changes in rat testes without 
comparable changes in other organs. 
The initial site of injury due to cadmium administration is not 
the germinal epithelium. The vasculature of the testis was shown to be 
the initial site of cadmium injury in several reports. Cadmium induces 
hemorrhagic necrosis in testes devoid.of germinal epithelium such as in 
the testes of rats subjected to long term cryptorchidism or triethylene-
melamine treatment (Gunn.et al., 1963), vitamin E deficiency (Mason et 
al., 1964), or .hypophysectomy (Gunn et al., 1963). Electron microscopy 
studies by Chiquoine (1964), confirmed that primary vascular lesions 
preceded all other changes in the parenchymal elements of testes. 
Gunn and coworkers (1965) reported that following interference 
of rat testes circulation, either from cadmium injury or surgical 
ligation (partial or complete), interstitial cell tumors developed. 
Moreover, these tumors form at the same rate and appear to have iden-
tical morphological characteristics. 
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Although cadmium may be a useful agent in the investigation of 
testicular function, the high degree of selective t~xicity for testicl,1-
lar vasculat~re resulting in permanent damage to .the testicular paren-
chyma. and the tendency to · induce neoplastic . tissue ·· makes this mineral 
element undesirable as a male an.tifertility agent. 
Sperma:togenic Inhibitio~by Chemical Agents 
The chemical approach to male fer~ility control has received con-
sider.able attention. · Excell'ent reviews :pave been prepared on the 
effect of drugs on spermatogenesis,by Fox and Fox (1967) and Gomes 
(1970) • 
During studies of the cytostatic and cytotoxic effects of numerous 
chemical agents it was noted that ac;l.ministration of specific chemicals. 
res·ul ted in damaged germinal epithelium in various. species of animals; 
nitrogen mustards produced atrophic testes in men (Spitz, 1948), and 
damaged spermatogonia and spermatocytes in mice (Landing et .. al. , 1949) ; 
furadroxyl, a nitrofuran, caused extensive damage to the germinal epithe-
lium of the rat testis (prior and Ferguson, 1950); triethylenemelamine 
(ethyleneimine derivative) was reported by Hendry et al., (1951) to. 
cause spermatogenic arrest and testicular destruction in dqgs and rats. 
Alkylating Agents 
Chemotherapeutic alkylating agents undergo chemical re.actions. 
generating highly reactive electrophilic carbonium ions that readily 
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form covalent linkages (alkylate) with various nucleophilic substances, 
including such biologically important moieties as phosphate, amino, 
sulfhydryl, hydroxyl, carboxyl, and imidazole groups (Ca],abresi and 
Parks, 1970). The alkylating agent's most important pharmacological 
actions are those that disturb the fundamental mechanisms concerned 
with cell growth, .mitotic activity, differentiation, and function. The 
ability of these drugs to interfere with normal mitoses and cell divi-
sion in rapidly proliferating tissues provides a basis for their in-
hibition of spermatogenesis. 
Nitrogen Mustards. Early work by Spitz (1948) indicated that 
twenty-seven to thirty men treated with nitrogen mustards for thera-
peutic purposes demonstrated atrophic testes on postmortem. Landing 
and coworkers (1949) reported microscopic changes in spermatogonia and 
spermatocytes of mice within twenty-four hours after administration 
of three nitrogen mustard compounds. Jackson and coworkers (1959) and 
Jackson (1966), using serial mating techniques to evaluate the male 
antifertility effects of several nitrogen mustard compounds reported 
no effects except with nitrogen mustard oxide in high doses. When rats 
received a dose of nitrogen mustard oxide (20 mg/kg body weight) over 
four days, fertility was absent and mating decreased during this first 
week of treatment, and the rats were subfertile during the fourth 
week. Jackson (1961) expressed the view that, lethal or nearly lethal 
quantities .of nitrogen mustards are necessary to significantly reduce 
spermatogenesis and fertility in.rats. 
Ethyleneimine Derivatives. Ethyleneimine derivatives are one of 
the principal cl'lemical agents (amo.ng alkylating agents) that exhibit 
selective interference with spermatogenesis. Triethylenemelamine 
given to rats in small doses ( 0. 05 mg/kg body weight, I. P. ) produced 
infertility even though sperm were present (Jackson and Bock, 1955). 
Lar-ger doses ( 0. 2 mg/kg of ·triethylenemelamine resulted in infertile 
rats the fourth week following a single treatment for reduced fer-
tility prior to thai; time. Normal fertility was regained the fifth 
week after initiation of treatment (Bock and Jackson, 1957). 
A variety of ethyleneimine derivatives have been examined and 
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their effects on fertility found to be qualitatively similar, Accor-
ding to the dose and compound used, antifertility effects ranging from 
selective to complete destruction of-the seminiferous epithelium can be 
achieved, without interference with libido (Jackson et al., 1959). Low 
doses of these derivatives produce sterility in rats and mice, resulting 
from an action on spermatids. Higher doses produce a biphasic infer-
tility pattern, including an antispermatogonial effect associated with 
aspermia. 
Following a single intraperitoneal injection (10 mg/kg body 
weight) of .1, 4-dimethanesulfonoxybutane (busulfan, Myleran), male 
rats remained fertile for seve_n to eight weeks, but became completely 
infertile during week eight to.nine. Infertility persisted for one to 
four additional weeks depending on th.e dose administered (Jackson; 1959). 
The action ofstra:i,.ght-,-chain monoester of methanesulfonic acid is 
confined to spermiogenic cells, whereas the isopropyl ester affects all 
premeiotic cells. Diesters have a wide range of antifertility action 
in the rat with the spermatogenic cell stage affected varying with the 
compound used {WHO Bulletin Number 424, 1969). 
All the chemotherapeutic alkylating agents may affect DNA molecules 
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of cells to cause miscoding with ·ultimate substitution of an adenine-
thymine base pair·for a guanine-cytosine base·pair, opening of the 
imidazol ring or depurination by excision of guanine residues and cross~ 
linking of . two nucleic acid .-chains. Any ef · the al;>ove. effects could. pro-
duce cytotoxic or mutagenic effects. The toxicity or mutogenic effects 
of alkylating agents ma:ke them undesirable·for use as male antifertility 
agents in human·populations. 
Nitrqfurans 
The_nitrofurans are a class of aromatic nitre compounds which have 
proven.effective as cytostatic agents (Prior and.Ferguson, 1950). The 
feeding of 200 mg/kg body weight of fu;radroxyl per day to rats resulted 
in e~tensive damage·to the germinal epithelium of the testis. The de-
generative changes begari four to eight·days after onset·of drug admini-
stration. At·the end of·one week, the sperm, spermatids, and sec~ndary 
spermatocytes were absent. or exhibited .abnormal morphology. Regenera-
tive :changes were.observed and·normal appearing tubules were present 
four weeks. later (Prior and Ferguson, 19.50) • 
Investigations by Nelson and Steinberger (1952) confirmed·the 
results reported by Prior and Ferguson. These investigators stated 
that spermatogenic·arrest occurred in rats feg. 1.5 g per.kg. diet for 30 
days at the primary spermatocyte stage while body weightt growth, .and 
androgen production were impaired only slightly. 
Nelson and Steinberger (19-53) reported.the effects of three nitro-
furans (fu:r:-aci:n, furadroxyl.and furadantin.) upon male reproduction.· The 
minimum effective levels per kilogram of·diet in animals thirty to 
thirty-five days of age, treated.until sixty days of .age were: furacin 
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0.2 g, furadroxyl 0. 75 g and furadantin 1.5 g.. That testicular damage 
is not permanent was,shown by the fact that animals maintained on the 
drug for one·hundred. days completely recovered as manifested.by fertile 
matings·after sixty to .one hundred twenty.days. 
Paul et al., (1954) reported that furacin inhibited the formation 
of acetyl cdenzyme A from pyruvate. This action by a nitrofuran could 
ac.c<!lunt f<!lr the. body weight depressing action of the high doses neces-
sary to.inhibit spermatogenesis. Such side effects prG>hibit the use 
of nitrofurans as antifertility agents. 
Bis(dichloroacetyl)diamines 
Thebis(dichloracetyl)diamines that have been tested have been 
found to suppress spermatogonia, spermatocytes and·spermat.ids without 
affecting gonadotr<i)phin secretion in.rats, mice, guinea pigs, dogs, and 
monkeys.· (Coulston et al., 1960), (Drobeck and Coulston, 1962). 
Heller and coworkers (1961) tested two of these compounds, N, N' 
(p-phenylenedimethylene)_ bis ( 2, 2-dichloro-N-ethylacetamide) in man. 
Courses.of treatment caused a gradual fall in sperm counts to a very 
low level in eight-to ten weeks. Their slow action and incomplete in-
hibition of spermatogenesis limits the practical application of these 
chemicals as male·antifertility agents. 
Spermatogenic Inhibitonby.Gonadal Hormones 
The. ability of .steroidal hormones from the gonads to inhibit 
spermatogenesis bears cl.ose.scrutiny. This antispermat0genic function 
probably is derived from the feed-back of such hormones on the hypo-
thalamus to. control pituitary gonadotrophin release. 
Estrogenic Inhil;;,ition of Spermatogenesis: Severe damage.has been 
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observed in teste~ of rats (Ludwig, 1950); (Ste,inberger and Nelson, 
1955); men. (Heckel and Steinmetz, 1941); bulls (Cupps, 1960); boars 
(Wallace, 1949) and hamsters (Bacon and Kirkman, 1955), following 
estrogen administration. The su~pression of spermatogenesis by estro-
gens is considered to be a secondary response resulting from suppression 
of· circulating gonadotrophin. level.s ·(Ludwig, 1950) ; (Steinberger, and 
Nelson, 1955). 
Ludwig (195Q) administered.estradiol (8.4 µg/day) to thirty day 
old male rats until they reached sixty days of.age. This level of 
estrogen produced germinal epithelial inhibiti.on and atrophy of tes-
ticular interstitial tissue that was evident on .histological examina-
tion .of the testes at sixty days of age .. The inhibition of the· 
spermatogeni.c process was comparable te. that found in.hypophysectomized 
rats, with spermatogonia and primary spermatocytes the only stages 
present·in seminiferous tubules •. Steinberger and Duckett (1967) ad-
ministered.estradiol benzoate in graded doses to rats: one to ten 
days - 10 µg; ten to twenty days - 20 µg; twenty to forty days - 30 µg; 
forty to sixty days - 40 µg. Their results confirmed those of Ludwig 
in that the seminiferous tubules were markedly reduced in size and 
that inhibition of the spermatogenic process occurred at the primary 
spermatocyte stage. 
Testicular degeneration has been reported inman following treat-
ment 'with stilbes.terol (Dunn, 1941) and other estrogens, (de la Balze 
et al. , 1954) • However,. the potential of estrogens to produce femi-
nization in the male precludes their consideration as a male anti-
fertility agent. 
Progestational Inhibition of Spermatogenesis. Many studies have 
been.reported regarding the.effect of progeste~one or progesterone-
like drugs: cm female fertility. However, there .is a paµcity of in-
formation about the effect of progestins on male anima~s. 
Heller_ et aJ,. ,. (1959) reported the. effects of progesterone and. 
synthetic progestins uppn the reproductive physiology of-normal men. 
FollG>wing four weeks of daily intramuscular injections of 50 mg pro-
gesterc:me four of five men were. azoospermic. . Libido and testicular 
size were reduced and gynecomastia occurred in two ·subjects. Such 
side effects-raise serious objections.to the use-of progesterone as 
a male antifertility agent. 
The synthetic. progestins, (Norlutin, Enovid, and ethyny_le-
estradiol-3-methyl·ether) seemto reduce spermatogenesis via gonado-
trophic hormone depression (Heller ~ al. , .1959) • Another SY;nthetic . 
progestin, Nilevar depressed spermatogenesis and decreased gonado-
1/ 
trophic hormones. without inq.ucing estrogenic actions. Such ebser-
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va.tions. led to further __ studies of the action of progestational agents. 
Cyproterone acetate (6-chloro.,.60 dehydr_o-17 alpha acetoxyl-1, 2 
alpha-methylene progesterone) is the most potent progestin yet en- · 
countered (250 times as active as progesterone when administered by 
injection). This synthetic steroid, although a potent progestin has 
received-more attention as an anti-androgenic substance •. Cyproterone 
acetate is a cempetitive inhibitor of the stimulatory effects of andro-
gens.including the maintenance of weight and normal histology of the 
seminal vesicles and the ventral· prostate (Neumann ~ al._, 1966) 
(Goldfoot et .al.·, 1971) (Walsh and Gittes, 1970). 
The contrac;eptive properties of cyproterone acetate have been 
demonstrated in rats (Whalen and Luttge, 1969) {Prasad~ al.; 1970). 
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Edwards (1970) reported the androgen dependent aggressive behavior of 
mice. was·unaffected by cyproterone aqetate while exerting strong anti-
androgenic effects on the seminal vesicles •. Although the anti-
fertility: properties of this synthetic steroidial anti-androgen appear 
to be excellent in laboratory animals such as rats, mice; and guinea 
pigs .the effect in man is vague.. Rausch'"".Stroomann et al.·, (1970) re-
ported that 100 and 200 milligram doses daily for nine months exhibited 
no effect on spermatogenesis in adult men. 
Further,work·_with cyproterone in the human may clarify the con-
fusing results reported to date. In light of the inconsistent results 
the.prospect for the·use of this synthetic steroid as an antifertility 
agent are not as good as for the .use of a.natural steroid. 
Testosterone Inhibition of Spermatogenesis. It has been demon-
strated that testosterone decreases.the peripheral blood levels of 
follicle stimulating hormone.and interstitial cell stimulating hormone 
in male mammals. Ludwig (1950) reported that 60 day old rats given 
O.l mg testosterone propionate daily for 30 days resulted in a.de-
creased gonadotrophic potency of -.their pituitary glands to only 31 per-
cent of the control animals. She administered varying doses (0.1 mg, 
1.0 mg., and 3.0 mg) of testosterone propionate to 60 day old rats, 
daily for 30 days~ Using ovarian weight increases of .immature female 
rats following injection of a suspension of pituitaries from the 
treated.and CC;)ntrol rats she reported gonadotrophic potency decreases 
of·. 69, 87 and 88 percent respectively for the three treatment groups •. 
Steinberger and Duc;:kett (1968) reported a drop in pituitary FSH 
levels and an elevation of plasma FSH levels shortly after castration 
of male rats. Administr.ation of. testosterone. to castrated male rats 
prevented the drop in pituitary FSH levels and rendered blood levels 
undetectable. These results support the hypothesis that testosterone 
has an inhibitory effect on the release of FSH·from the pituitary 
gland. 
Watanabe and Mccann (1969) reported a.decline in hypothalamic 
follicle stimulating hormone releasing factor, following castration 
of adult male mice, which was apparent within 8 and persisting for at 
least 29 days postoperatively. When intact rats were.treated with a 
large dose of testosterone propionate (2 mg/day) for 2 weeks, there 
was·. no co:p.sistent alteration in the level of stored follicle stimula-
ting hormone releasing fac.tor. These results are consistent with the 
view that increased testosterone levels in the peripheral blood in-
hibit the release of follicle stimulating hormone. 
Pelletier (1970) reported that a single intramuscular injection 
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of 400 milligrams of testosterone propionate into a castrated ram de-
creased the plasma leutinizing hormone level significantly by the first 
day after treatment. Moreover, the plasma leutinizing hormone levels 
remained at a very low level for 5 to 7 days, returning to normal after 
day 9. These reports suggest that testosterone blocks the.discharge 
of leutinizing hormone. 
The inhibiting effects of the male sex hormone on testis weight 
and spermatogenesis was reported by Ludwig (1950). She found that 
testis weight of rats receiving doses of 0.1 mg of testosterone pro-
pionate (TP) daily were reduced 25 percent from control testis weights. 
In contrast testis weights of rats receiving 1.0 and 3.0 mg TP/day were 
reduced only 17 and.8 percent respectively. Histological evidence 
showed that inhibition of spermatogenesis paralled the loss of 
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testicular weight. Thus, the above results suggest that low dosages of 
TP decrease gonadotrophin release from the anterior pituitary but are 
insufficient to maintain the seminiferous epithelium. 
Heller and coworkers (1950) tested the effect of exogenous tes-
tosterone in men. Thirteen men received 25 milligrams testosterone 
propionate daily for 24 to 29 days. Biopsies taken at the cessation 
of the treatment indicated that damage included sclerosis and hyalini-
zation of the membranes of the seminiferous tubules, atrophy and 
necrosis of germinal elements, disappearance of the Leydig cells and 
arrest of sperm formation. Biopsies, performed 5 to 6 months after 
treatment was stopped, indicated partial recovery of the testicular 
parenchyma. Subsequent biopsies taken, up to 31 months after stopping 
treatment, revealed marked improvement over the biopsies taken at the 
end of the period of testosterone administration. This experiment 
proves two important facts: first, azoospermia can be produced in man 
by the. administration of testosterone and second that the azoospermia 
is reversible, 
From studies reported by Woods and Simpson (1961), maintenance of 
accessory sex organ weight was accomplished with doses of testosterone 
propionate much lower than doses that would stimulate spermatogenesis 
in hypophysectomized rats. Therefore, since·low doses of testosterone 
inhibit the release of pituitary gonadotrophins but do not maintain 
spermatogenesis it may be possible to administer chronic low dosages 
of testosterone which will maintain the peripheral blood level of the. 
hormonal steroid at normal levels, maintain libido and accessory sex 
organs of an intact animal whil.e inhibiting spermatogenesis. Thus the 
critical problem becomes one of finding the best method of administering 
testosterone over a long period of time at a constant rate to an animal. 
Silicone Rubber as a Carrier for Prolonged Drug Therapy 
While performing in.vitx:o studies on artificial heart valves, 
Folkman·~ al., (1964) noted that silicone.rubber (Silastic) possessed 
the.property of .. absorbing certain dyes from solution and subsequently 
giving off these dyes. This observation suggested:that silicone im-
pregnated.implants might serve as a mode of administering various 
pharmacological agents to man over prolonged periods of time •. · 
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A substance which can ac~ as an intermediary between.an animal's 
body and foreign .mate:i;-ials to be administered to the animal should have 
certain characteristics. Scales (1953) defined properties necessary 
for an ideal soft tissue sl.lbstitute: 1) not physically modified by 
soft tissue; 2) chemically inert; 3) does not cause inflammation or 
foreign body reaction;.4) noncarcinogenic; 5) produces no ·state of 
allergy or hypersensitivity; 6) capable of resisting mechanical strains; 
7) c~pable of fabrication in the form.desired; and 8) capable -of steri-
lizat.ion.. The· .silic.ones have been found to have. these properties to a· 
degree sufficient to make.them very useful for long-time subdermal con-
tact in an a:r;iimal's body (Braley, 1965). 
Steroid. Diffusio_n Through Silicone . Rubber Membranes 
Dzuik and·cook (1966) placed steroids in silicone rubber capsules 
which were th.en incubated.in·saline solution at 37.5° C. Estradiol; 
progesterone, androgestenedione, testosterone, cortisone, 6 alpha-
methyl-17 alpha-acetoxy-progestrori.e; and 17-acetoxy-6-methyl-16-
methylenepregna-4; 6 diene-3, 20-dione were.all foundto pass through 
the capsules into· sali:r;ie soluticm at. quite constant rates f0r several·. 
days. Capsules containing one of. the steroids, megesterol ace.tate, 
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were implanted subcutaneously.in.normal-cycling ewes. The incidence of 
estrus was reduced during .the 34 day period whi:Le· the implants were in 
place. Estrus was resumed upon removal of the implants. 
Further evidence of steroid diffusion through polyditt1ethylsiloxane 
(PDS·) membranes was· provided by. Kincl et al. , ( 1968) • This research 
greup conducted experiments on the diffusion of several steroids through 
PDS membranes into distilled .water. Testosterone was found to diffuse 
out of .the PDS capsules into distilled water at a rate o~ 2.6 µg/hr per 
100 mm2 surface.area and wall thickness of 0.508 mm. Moon and Bunge 
(1968) showed that enqugh testosterone.was released through the wall of 
PDS capsules over a 16 week period to maintain the accessory sex glands 
of·mature castrate male rats. 
Tbat continuous dosage of steroids via PDS capsules implanted. 
subcutaneously en:bances the biological effect of steroids in rats and 
rabbits was shown by comparing subcutaneous injection, gavage; and PDS 
routes of adm.:l.nistration (Chang and.Kine!, 1968). From 6 to 25 times 
less megesterol acetate was needed via the PDS implants to produce com-
parable biological effects. The same workers (Chang and Kine!, 1970) 
reported tha~ testosterone-filled PDS capsules were thirty times more 
active than an oil solution of testosterqne in the parabiotic rat assay 
and about fifteen times more active in androgenic test in castrated adult 
male rats. 
Silicone rubber exhibits properties which are attractive for 
chronic administration of testosterone. However, the release rate, 
over prolonged time periods needs more investigation and the release 
rate needed to effect spermatogenic inhibition without concommittant 
accessory sex-.. organ hypertrophy must ·be elucidated •. 
Summary 
Research in fertility control in the .male.has been carried out 
largely in laboratory animals using both.chemical.and immunological. 
appr0aches. Immunological processes present hazards when used in man 
and they suffer fr0m a lack of specificity. Similarly, none of· .the 
chemical agents described in the preceding sections are suitable for 
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use in man due. to slow aa:tion, incomplete inhibition of spermatogenesis, 
mutogenicity, and known or potential toxicity. 
The-preceding review demonstrates that spermatogenesis depends on 
gonadotrephin.stimulated testosterone secretion by the.interstitial 
cells of Leydig. The local·concentration of testosterone required to 
maintain spermatogenesis is greater than the peripheral _level of tes-
tosterone. necessary for maintenance of accf:?Ssory sex organ function 
and brai_n -stimulation. Perhaps the _ development of techniques that 
would permit·testosterone to be administered at constant rates for pro-
longed periods would be_a valuable procedure te inhibit spermatogenesis 
without_producing undesirable side effects. 
The_relations.hip between PDS capsule dimension and testosterone 
release rate,- the effect of a specific dosage of testosterone upon 
spermatogenesis, libido anc1 accessory sex organ function in male rab-
bits_ must be established to test the hypothesis that a continuous ad-
ministration of testosterone-via the appropriate sized PDS capsules 
implanted into male rabbit$ will inhibit spermatogenesis without pro-
ducing accessory sex organ hypertrephy. 
CHAPTER III 
MATERIALS AND METHODS 
Materials 
Silicone, Rubber· 
PolydimethylsilQxane capsules were prepared from Silastic Medicah 
Grade Tubing ,purch_ased fr0m Dow-corning Corporation through the Mid-
west Surgical Supply, Oklahoma .city, Oklahoma_. Two sizes of tubing 
were used in this study; 1) catalogue number 602-331, inside diameter 
3 ~- 35 millimeters, QUtside diameter . 4. 65 millimeters and wall thick-
ness. 0. 65 millimeters, 2) ca~alogue number 602-331, inside diameter 
1.47 millimeters, outside diameter 1.96 millimeters and wall thickness 
0.245 millimeters. 
Dow-corning Medical Adhesive Silicone.Type A was used.to seal the 
ends of the ·various lengths of-silicone rubber· tubing. This particular 
adhesive cures to a firm, ·non-sticky consistency within 24 hours in a 
water vapor· atmosphere. 
Animals 
Mature male New Zealand White Rabbits were acquired from the Red-
WOQ<i3._ Game Farms, Salt Lake City, Utah. 
Steroids 
Testosterone (17 beta-:-hydroxyandrost-4-ene-3-one) was obtained 
frem Sigma-Chemical Company and cholesterol (5-cholestin-3-ol) from 
-:,, 
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Steraloids, Inc., Pawling, New York. 
Radioactive Isotopes 
Testosterone-l,2-3H was obtained from New England Nuclear Cor-
poration, Boston, Massac~usettes and was purified via thin-layer chro-
matography. Purity was checked by a radio-chromatogram scanner (Packard, 
Model 7201) and identity confirmed by the use of authentic testosterone 
standard in adjacent lanes on the thin layer plates. 
Tritiated toluene, 2.28 x 106 dpm/g, ~as obtained from Packard 
Instrument Company, Inc. , Downers Grove, ·Illinois and used as tritium 
standard in the calculation of quench correction curves. 
Scintillat.ion Counting. Material 
Two scintillation fluids were used in this study. 1) Aquasol 
purchased from New England Nucl.ear, Boston, Massachusetts; and 
2) toluene scintillation fluid·containing 12 g of 2,5-diphenyl0xazole 
(POP) and 0.12 g of l,4-bis-1-(5 phenoxazolyl)-benzene (POPOP) in 3 
liters spectroquality toluene. The latter mixture was allowed to 
equilibrate at least 24 hours before use and stored in the dark, 
Reagents 
The-nanograde solvents o~tained from Mallindkrodt Chemical Works 
included dichloromethane, e.ther, benzene, ethyl acetate, toluene and 
methanol. Water used in the procedures was distilled two times over. 
glass, ether-washed and redistilled. 
Silica Gel 
Silica gel (Silica TLC-7GF, Mallinckrodt) was washed three times 
with dilute acetic acid over a scintered glass filter, followed by 
three rinses in boiling triple-distilled water and washed two times 
with. boiling methane!. The silica gel was'.dried 24 hours at 110° c. 
Thin layer chrematography plates were poured (0.25 mm thick) with 
slur:i;-y containing 33 g silica gel to 78 ml water. 
Glassware 
33 
Immediately after use glassware was rinsed, soaked in detergent, 
brushed and placed in chromic ac:id overnight~ Follewing seven to 
eight tap water rinses, the.glassware was.soaked in detergent, rinsed 
again with tap water and·. placed in dilute hydrochloric acid, The acid 
bath was followed. with rinses as follows: ten times with tap water, 
ten times-with distilled water and two times with nanograde methanol. 
The glassware was· .. subsequently air dried at ·room· temperature. 
SolutiCi>n for Tissue Homogenization 
The solution used for homogenization of testicular ana epididymal 
tissues was prepared by mixing 9 g NaCl, 0.5-ml Triton X-100, and 0.1 ml 
of .. 1.0 g/ml Methiolate solution in 1 liter of glass distilled water. 
Triton X-100 was added to prevent fat emulsification which sometimes 
obscures cells and methiolate to retard bacterial proliferation (Amann 
and Lambiase, 1969). 
Tissue.Fixative Solutions. 
Zenker-formol fixative solution was used for testicular tissue. 
Zenker stock base is prepared 24. hours before use as follows: 50 g 
mercuric-chloride, 25 g potassiuil), dichremate, and 10 g sodium sulfate 
are-mixed into sufficient distilled water to make 1,000 milliliters 
of solution. Inunediately prior to the addition of testicular tissue 
5 ml of 40 percent formaldehyde is added to fix one.rabbit testis. 
Methods 
Recrystallizztien of Steroids 
Testosterone and cholesterol, were purified via recrystatlization 
(Axelrod ~ al., 1965) . 
Testosterone •. One gram of testosterone (Sigma Chemicals) was 
placed, in a 35 ml ccmioal vial. Methanol (nanograde, Mallinckrodt) 
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was added with a pasteur pipette while the vial was suspended in water 
at 70 to 80° c. A minimal quantity of methanol was added to dissolve 
the testosterone. The vial was removed from the water bath, held at 
room. temperature for four hours, ·followed by four hours at 5° C then 
twelve hours at -20° c. The methanol solution was removed; the crystals 
dissolved in fresh methanel and recrystallizea again. The melting 
point was determined after the secend recrystallization (Thomas-Hoover 
Capillary Melting .Point Apparatus) and recrystallization repeated un-
til a constant melting point was obtained (153° C). The crystals were 
placed in.a vac~um jar containing phosphorus pentoxide and dried far 
72 hours.· 
Cholesterol. The-same.method of recrystallization was used.for 
cholesterol as for testo$teronewith the exception that methanol: 
ethanol (1:1 v/v) was used fer the.solvent and that the melting point 
was 148° c. Although this method.will not provide cholesterol of high 
purity it was sufficient for the purpose of this investigation. 
Check sf. Identity: and· J?uritY' ·of· Testoster.one--1, 2-3H 
Thin layer chromatography was used to check the identity and. 
purity of-testosterone..,.1;2-3H (New England Nuclear). A 50 microliter 
aliquot of testosterqne-1,2,....3H · .. (New England, Nucl:ear).. A 50 microliter 
aliquot of testostefone~l,2-3H was spotted on a-thin layer plate. Au-
thentic testosterone was-placed on an adjacent lane of.the same plate. 
The.plate was,developed in benzene·: ethyl acetate, 55:50 (v/v), air 
dried and the Rf of authentic testosterone determined-visually with 
UV light. The Rf ef the test()sterone-l,2-3H was determined by sub-
jecting the thin layer plate tea radio chromatogram-scan. The-iden-
tical Rf of ·the·testosterone-1,2,...3a and the unlabeled testosterone 
was accepted as proof that testosterone-l,2-3H.was essentially pur.e. 
Preparation of· 'l'rit:i;um: .r:.abe_lE?d: Testes.terone 
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Purified testosterone ... :L,2,-3H (thin layer chromatography) of known. 
specific -activity and known. volume was added to a 3.5 · ml conical tube 
then dried under a stream of nitrogen •. A known amount.of testosterone 
recrystallized to a constant melting ·point was added to the vial. The 
crystals were dissolved in a minimum amount of hot methane! and cooled 
slowly·. as described in the testo_sterone . recrystallization method. 
After crystal fermation occurred the mother liquor -was placed in a .. 
wate:r;: bath. (60° C) · until·. the vial was wa:r::m · to the touch and glass dis-
tilled water added drop-wise until a white .cloud:-like precipitate 
lingere~ in solution. The solution was removed from the water bath and. 
slowly cooled as -pr~vieusly described. ·· Approximately 95 percent of the 
original. mass of te.stosterone crystals were recovered-by repeating the· 
abeve procedure several times. The-crystals were _dried as described 
previously. 
s.secific Ac.tivity of Testosterone-1.,2;-3H Used.to Pack .PDS Capsules 
The specific activity was determined by determining the mass of 
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a single crystal via a Cahn Electronic Balanqe and measuring·the radio-
activity of tha1;: crystal.utilizing a Packard liquid scint~llation 
spectrometer, Mode.l 3003. 
Po_ly~iine~yl~iloxane .. _ Capsul.e,..:'Brepa.ra tion 
Silas tic Meq.ica]. Gra4e · (Dow-,CGrning Cerporation) silicone rub_ber 
tubing was used to prepare all the capsules. Tubing with inside and 
eutsi.de diameters of· 3 .JS mm and· .4. 65 ·mm .respectively and -thickness of 
0.65 was ·selected :Se~ Experiments -1, 2.,. .and 3. Tubing with inside and 
outside diameters of 1.47 mm.,and 1.96 mm, (0.245 mm thickness) respec-
tively was, _selected : fer Experiments 4 and· 5. • 
The tubing_ was._ cleaned by washing ·in .a: het water-seap solution .to 
remove.sodium bicarbonate (dusted.on surface to facilitate handling) 
ang other surface contaminates. Ivory Flakes was.used.since oily soaps 
or,synthetic detergents a~e contraindicated due.to the property of 
Silastic to absorb the latter.materials. Thetub:i,.ng was rinsed with 
hot tap water,.distilled water, and air dried. The desire4 length of 
tubing was cut, one end.sealed with 3 mm of Dow's Medical Adhesive 
Silico.ne Type A-and allowed to cure at room temperature and.atmosphere 
for 24 hours. PDS· .. tubing with one end sealed ·and cured was filled to 
the desired· length with :testosterone-tritium (SA.= 1900 cpm/ug) for 
Experiments 1, 2, ,and 3 and. unlabeled testosterone or.cholesterol fer 
Experiment A and .5. The open end .was sealed with. Medical .Adhesive 
Silicone.Type,A and cured• as previously described. 
Protecol ·fer· Oal-oulationi. of' 'PD'S ·Capsu:le Surface .Area. Stud.ies 
from several labora,tor:i,es h~ve shown.that ster~ids diffuse through 
PDS at ra.tes .proportie:>nal to membrane area and inve,rsely preportion~l 
to. membrane thickness (Garrett ancl Chemburkar, 1968; Kine! et al., 
1968; Kratochivl et al., D.970). 
The surface area of a ._cylinder equals the circumference times the 
length. The-circumference of a cylinder equals two times e_ times the 
radius of the cylinder; hence the surface area of a cylinder equals 
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two times e_times the radius time:;; the length of the cylinder. The 
external surface area (area of the.membrane in contact with body fluids 
when implanted) of the l?DS capsules is reported in this study. The 
circumference was calculated from the outside diameter of the Silastic 
tubing as given in the specifications from the Dow-Corning Corporation. 
The length of tubing used in calculation of surface area was the actual 
length of tubing filled with testosterone. 
Scintillation counting 
Water Sample Preparation. One milliliter aliquots of water 
bathing the testosterone-tritium filled PDS capsules (Experiment 1) 
were added to 14 ml of Aquasol (New England Nuclear), shaken, cooled 
at 5° c for.four hours then counted in a Packard Tri-Carb Liquid Scin-
tillation Spectrometer, Model 3003, using the Automatic External Stan-
dard to determine the percent efficiency ef·the counting procedure. 
The mean.of three ten minute counts minus background was,used for 
calculation of-the tritium concentration in the water. 
Plasma.sample Preparation. Plasma samples from Experiments 2 and 
3 were.thawed with a stream of warm air, l ml pipetted into 14 ml of 
Aquasol, mixeq well by vigorous shaking and allowed to equilibrate 48 
hours at 5° C prior to counting. The equilibration time was.necessary 
with plasma samples to obtain consistent counts from each vial. The 
mean of three ten minute counts·minus background was.used.for calcula-
tion of tritium :concentration in the plasma. 
Quench Correction.. The object of this procedure was to utilize 
the Automatic External Standard (137 Cs) device of a Packard Tri:-Carb 
Liquid Scintillation Spectromete:r;-, 'Model 3003, ,to .determine the ·indi-
vidual counting efficiency fo.r each sample. 
38 
A rectangular coordinate system was-.used to construct a quench 
curve from a one-to-one correspondence between sets of points in a 
plane. Percent ef counting efficiency was designa,ted as points on the 
ordinate (y axis) and counte; perminute in.the Autematic.External 
Standard (blue channel) was designated as points on.the abscissa (x 
axis). Such a.curve must be prepared according to a given .set of spe-
cifications: 1) type of scintillatien fluid, 2) standard source.of 
radioisotope or.isotepes, 3} quenching agent used, and 4) liquid 
scintillation-spectrometer settings adjuste~ for single label or double. 
labe], counting. 
For this study· a quench curve for tritium in Aquasol scintillation 
fluid was de$.ired. Nitromethane·was·used as a quenching agent, tri-
tiated toluene as a source of radio"7activity., ·and the measurements were 
made.with single label settir;i.gs·onthe :liquid sci;ntillation spectrometer. 
The fellowing ma terial1;1 were added· to 18 sci.ntillation vials: 
14·. 5 ml ef Aqua.sol . to all vials, 0 .1 ·ml . tri tiated toluene to 16 vials, 
and nitromethane. in graduated amounts (0.0005, 0.01, 0.05, 0.08, 0.10, 
0.26, and 0.40 millilite:i:::s) to duplicate vials (14 total vials). 
Thus two vials contained only Aquasol·to provide background 
measurements, two vials contained no quenching agent to. previde 1radio-
activity measurement of the tritium used as a.stan4ard.and feurteen 
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vials contained tritiated toluene.plus graduated.amounts of quenching 
agent. Each sample was counted.for three periods of ten minutes each. 
The radioaotivi ty, of . the tritium standard equaled 2. 28 x 106 dpm/g ,. 
which was in a 10 ml volum,e of: ,toJ.aene,c The density of toluene equals 
0.8669 g/mL The 0.1 ml used irt each scintillation vial.represents 
6 -2 5 (2.28 x 10 dpm/g times 8.669 x 10 g/0.l ml) 1.977 x 10 dpm/0.l ml 
of tritiated toluene. 
To determine the efficiency of the counting apparatus the fol-, 
lowing formula was used. 
Counting efficiency = counts/minute actua1ly determined. 
counts/minute expected from known activity 
The quench curve constructed with data from the above procedure 
(counting efficiency versus blue channel AES cpm) was then used for 
correcting the measurement of radioactivity in each sample from Ex-
periments 1, 2 and.3. 
In Vitro Release of Testosterone from•Pos·capsules 
Testosterone-tritium filled PDS capsules with the ends properly 
cured were rinsed with methanol, dried and placed in Erlenmeyer flasks 
containing 100 ml distilled water. One millimeter samples were with-
drawn at 6, 12 and 24 hours. The·! ml of bathing media was added to 
14 ml Aquasol scintillation fluid, equilibrated.in the dark at 5° c for 
l hour then counted in a .Packard Liquid Scintillation Spectrometer, 
Model 3003. To identify the tritiated material in the water bathing 
the testosterone-tritium filled PDS capsules, 100 ml of the incubation 
water was extracted three times with dichloromethane, the organic ex-, 
tract separated, dried under a stream of nitrogen and concentrated in 
the tip of the conical·tube with methanol. The residue in the tube 
40 
was·put intq sol'l;ltion with 1 ml of methanol, one-half milliliter was 
transferred to scintillation vial, dr.ied under nitrogen, toluene scin-
tilla:tion fl.uid- (POP, POPOP) added and counted on a liquid scintilla-
tion spectromete:t;" (Pac.kard, MOdel 3003) . The other one half milliliter 
of the extract was transferred to a TLC plate, .testosterone standard 
spotted on the adjacent lane and developed.in benzene:methanol (87.5: 
12 .5 v/v) • A chromatogram scan (Packard, Model 7201) was performed. 
The Rf value of authentic testosterone and the extract of the water 
bathing the capsules was· compared to identify the mate.rial in the 
extract. 
Animal Housing and: Preparatio:i:i. 
The rabbits used in this study were housed individually in an air-
conditicmed room cm a 14: 10 hour light-dark schedule an¢l provided with 
Purina .Rabbit Chow and water ad libitum. 
Three weeks acco~odation time was allowed for the rabbits after. 
arrival. They were treated for ear mites, teeth and toe nail problems 
during this time. 
Castrations.and subcutaneous and intraperitoneal capsule place-
ment'(Experiments 2 and 3) were performed with the.rabbits under 
pentobarbital sodium anesthesia. Sub.cutaneous implantation of cap-
sules in experiment 4 was made using a 12 gauge cannula and.a 15 gauge 
stylet without. anesthetic. 
A bleeding technique described by Hoppe, et al., (1969) was used 
to facilitate obtaining blood samples and avoid the mortality risk 
associated with repeated cardiac puncture. The blood samples for ex:-
periments two; three, and.four-were collected into oxylated tubes, and 
stored .in ice until the samples could be centrifuged to obtain the blood 
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plasma. The plasma was frozen at -5G c: until analyses were performed. 
Determination of Plasma Testosterone Concentration 
Testosterone was extracted, isolated and quantified via gas-
liquid chromatography equipped with electron capture detection as 
originally described by Brownie, et _!.l, 1964, and modified by Kirschner 
and Coffman, 1968. 
Preparation of ·,Pla.sma . fer Solvent Extraction.- Fifty microli ters of 
tritium .labeled testosterone standard (1,5-00 dpm of testosterone-1,2-3H) 
Wa$ pipetted into 80 ml ext-r-action tubes and evaporated to dryness under 
a stream of nit-rogen. Plasma samples from Experiment 4 were thawed and 
15 ml added to the _ extraction tubes containing labeled _standard.. The 
tube-was then gently vortexed and allowed to equilibrate for 30 minutes 
at-5° c. 
Extraction.and Alkali Washing. The plasma was extracted three-
times with 45 ml of ice-cold dichloromethane. The extract was evapora-
ted u:r;i.der nitrogen and the residue taken up in 30· ml of ethyl ether. 
Alkali wash was,accomplished,by adding 10 ml of 0.1 N sodium hy-
droxide solution to the ether. extract and gently inv.erting the tube 
twenty times. After removing the.alkali phase, the organic phase was 
wa$hed three times with 15 ml of water and evaporated to dryness under 
nitrogen. 
Chromatographic Isolation of Testosterone. Thin layer.chroma-
tography plates were marked into nine lanes, eight for samples, and.one 
for standard testosterone. The samples were spotted: in benzene and 
developed in benzene: ethyl acetate (55:50, v/v). Since samples did 
not centain sufficien.t. testGsterone te visibly absorb ultra-violet. 
light;, areas corresponding to the standard testosterone. were eluted. 
In ·this solvent system testostercme had an Rf of· 0. 3. 
Appropriate a:i:;ea.s,of silica ,gel containing testosterone were 
scr~ped from.the TLC plate and placed.in 35 ml conical tubes. This 
silica gel was extracted.th:i:.iee times with a benzene:water partition 
system, using 1 ml of benz-ene with. ten drops of water. The benzene 
fraction was pooled .in. 12 ml conical .centrifuge tubes and evaporated 
to dryness under nitrogen. 
FGrmatien of the Hep.tafiuorobutyrate Derivative. One hundredth 
milliliter of a 2, ·sol.ution of .heptafluorobutyric anhydride in hexane 
andtetra-hydre>furan was added to the sample tube. The tube was 
sealed and incµbated in a 60° C water bath for thirty minutes. After. 
refluxing, the sample was evaporated to dryness. 
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Chromatographic Iso.la.td.on: of Testosterone Heptafluorohutyrate . (THFB). 
Following concentration by benzene, the residue was spotted on a TLC 
plate, with benzene, and develo:r;>ed in benzene: ethyl acetate (87.~:12.5 
v/v). In this solvent.system TliFB had an approximat;e Rf of 0"5. The 
silica gel in ,the area co-ohromategraphing with the THFB standard was 
placed in .a 35 ml tube and.extracted three times with a benzene: water 
partition system.. These extractions were carried out, using 1 ml • 
benzene with 10 drops water •. '.The benzene was pooled and dried under 
nitrogen, Following the addition of 1 ml benzene, a 0.2 ml aliquot 
was taken for scintillation counting, a 0.5 ml ~liquot for gas-liquid 
chromatography. 
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Gas-Liquid Chromatography. A Selectra Series 5000 Barber-Coleman 
gas chromatograph equipped with a Model 5120 electron capture detector 
was used to measure the heptafluorobutyrate derivative of testosterone. 
Samples were applied in 5 to 10 µl of benzene. Au-shaped glass column 
91.5 cm long, with 4 mm. internal diameter), silanized with a 5% solu-
tion of dimethyldichlorosilane in toluene and packed with Gas Chrom Q 
(80 to 100 mesh) coated with 3% OV-225 (Applied Science Laboratories, 
Inc.), was used to effect separation of steroids. Column bath tempera-
ture was 200° c. Pure, extra dry nitrogen was used as a carrier gas 
with .an outlet velocity of approximately 100 ml/minute. 
The electron capture detector was operated in the DC mode and vol-
tage was adjusted to give a standing current 60% of that obtained at 
the plateau of the voltage input curve. The detector bath temperature 
was 240° c. Sensitivity and linearity of detector response to standard 
HFB derivatives of testosterone and 20S-OH progesterone were ascertained 
each day of data collection on GLC. Samples were not run unless the. 
response was linear over the range of expected THFB concentrat;.ion. The 
size of peaks was calculated as follows: Base x Height= Area 
2 
Mon,ito.:t:;ing Testo,sterone Loss Through the Method. Tes~osterone 
loss prior to GLC·was determined by measuring the loss of testosterone-
l,2-3H added to the plasma sample before extraction. After radioactive 
samples were placed.in scintillation vials, they were evaporated to 
dryness under nitrogen, and 12 ml of scintillation fluid (POP, POPOP), 
was added to each vial, The samples were counted in a three channel 
Packard Tri"-Carb Liquid Scintillation Spectrometer, Model 3003, equipped 
with a 137Cs Automatic External Standard device. Adjustments for 
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losses incurred during quantitation by GLC were made by the addition of 
an internal standard (25 nanograms :.wS-OH progesterone HFB per sample) 
as outlined by H0rninget al., (1963). 
Calculation e>f Testosterone··conoentrat;.ion. The amount ef testos-
terone in 1 ml of plasma was calculated according to a formula used by 
Stabenfeldt (1968). The formula used is as follows: 
Testosterone (ng/ml) =Rx C·x U x Ax 0.596 x Df x Xx P 
Where: 
cpm testosterene-L,:'2,...3H' added 'tlo the plasma 
R = - -
5 x cpm in 20% aliquot obtained.prior te GLC 
c = peak area (cm2) !l:C), .ng·,:2.Q~ ... OH prC>gestzersne HFB standard 
peak area (cm2) 10 ng THFB standard 
u = peak area (cm2)·THFB in sample 
peak area (cm2). 2013-0H progerterone HFB in sample 
A= ng 2013-0H progesterone HFB added as internal standard. 
0 , 596 = molecular weight of· testosterone 
molecular weight of.THFB 
Df = (100-hematocrit) (blood volume) 
[ (100-hematocrit) (blood volume) J - milliliter anticoagulant 
1 x = ------GLC aliquot 
1 
p = ----------------~ milliliters plasma extracted 
Sexual Behavior and Ejaculation 
A o.etermination sf sexual behavior was performed on all the animals 
of experiment four. Sex behavior was measured over a 20 day period, 
(April 15 to May 5, 1971) by taking two ejaculates per day on alternate 
days. This provided a total of twenty ejaculates per animal. Teaser 
does were placed in a buck's cage and sex behavior scored as follows: 
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Point ·spread.a to 10. Ten for rabbit ejaculating O and 60 seconds with 
routine female; nine for ejaculates between 60 and 180 seconds with 
routine female; eight -for ejaculates between O and 60 seconds with new 
female; seven for ejaculates between 60 and 180 seconds with new female; 
six whe.n buck mounts and thrusts vigorously with both females but does 
not ejaculate; five for mounting and thrusting vigorously only with the 
second or new female; four for mounting within Oto 30 seconds on rou-
tine .female but failing .to thrust vigorously; three for mounting within 
30 to 180 seconds on routine female but failing to thrust vigorously; 
two for mounting between Oto 30 seconds-on second-female but failing 
to thrust vigorously; one for mounting between 30 and 180 seconds on 
second female but failing to thrust vigorously; 0 for rabbits failing 
to mount either female, (MacMillan et al., 1969). The ejaculate was 
collected in a graduated collection tube and placed on ice as soon as 
possible. The seminal volume was determined-then the sample was cen-
trifuged in a Sorval at 5° for 10 minutes to sediment any cellular 
material, 
Analysis of Citric Ac.id in Seminal Plasma 
Citric acid in the rabbit seminal plasma obtained in experiment 
four was-quantified spectrophotometrically according to the method 
of Saffran et al., (1948). 
Analysis of .. Fructose. in Seminal_ Pla::;ma 
Fructose in the rabbit seminal plasma obtained in experiment four 
was quantified spectrophotometrically by the method of David et-al., 
(1967) . 
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Quantitation ofGonadal·Sperm Cells 
In experiment four, the testes and epididymidies were removed-from 
each rabbit and placed on a wet paper towel. The testis was dissected 
from the epididymis and the epididymis dissected into head-body and 
tail. Individual weights were then obtained for thhe paired testes, 
head-body and tail of the epididymidies. Approximately one-half of one 
testis was weighed, tunics removed.and the remaining parenchyma minced 
with scissors and homogenized in the micro-attachment of a Waring 
Blender. Similarly the dissected parts of the epididymidies were 
weighed, minced and.homogenized. 
The method described by Amman and.Lambiase (1969) wase used: One 
half of.the testis parenchyma was minced and ground in a Waring Blender 
for 1.5 minutes with 50 ml of SMT solution, placed in a 600 ml beaker, 
allowed to stand for two to three minutes, mixed by rotation of the 
beaker and a 10 ml sample pipetted into a 50 ml Erlenmeyer flask. 
Quantitation of spermatids and spermatozoa was accomplished by shaking 
the flask thirty times, removing aliquqt with a Pasteur pipette and. 
plac~ng aliquot on a hemacytometer chamber. Counting was begun after 
the suspension .had settled for approximatel.y three minutes. Two ob-
servers made duplicate counts of each sample. 
Calculation fo.r Converting Hemacytometer Counts to Sperm Cell 
Counts.. Calculations, are based.on the fact that counting is ca;r·ried 
out without further dilution after homogenization. These calculations 
are all based on a 5 square count or a count involving 80 small squares 
of a hemacytometer. The following equations were used: 
Number of·sperm cells= (number of cells countec;i) (1000) (4000) 
· number of small squares (80) counted 
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The above equation can be reduced to: 
Number of sperm cells= (number ef cells ceunted) (50,000) 
Tetal number of cells per 
unit·of tissue homegenized = 
(number.of cells counted) (50,000) 
(volume of homogenate) 
Number of cells per 
gram ef·tissue 
= number of cells/unit of tissue 
grams of tissue homogenized 
Total number of cells = (paired testes weight) (no. cells/gram) 
per pair of testes 
Calculation of Total Daily Sperm Cell Production. Daily sperm 
production (DSP) is the total number of sperm cells produced per day by 
two testes (Amann, 1970). The total number of sperm cells per two 
testes was determined from the above calculation. This represents the 
mature spermatozoa and spermatids from Stages VI, VII, and VIII .of the 
seminiferous epithelial cycle. The time required for cells to advance 
through Stages VI, VII, and VIII is 3.4 days as shown by Amann antl 
Lambiase (1969). 
The 3.4 days was used as the time divisor of total sperm cell 
count to derive total daily sperm production. 
Tissue Preparation for Histological Study 
Testes. A testis was placed in Zenker-:formol solution for fifteen 
minutes, removed and approximately l mm cut transversely from each pole 
of.the organ with a sha:i;-p razor blade. The testis was replaceq in the 
Zenker-:fermol solut:i,on for 24 hours, removed and washed under a con-
tinuous flow of cold tap water for 24 hours. The tissue was then placed 
in 70% ethanol and 4 micron sections cut and mounted on slides which 
were stained using the periodic acic;l-Schiff technique. 
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Experimental Design 
The primary objective of this investigation was tq find a method 
of administering low doses of .testosterone which inhibit spermatogenesis 
without depressing libido er.producing accessory sex organ hypertrophy 
in male rabbits for 3 months. 
Expe:dment 1 :. Release. of Testosterone-Tritium· from P0lydimethylsiloxane 
(PDS) Capsules into Distilled Water 
Tha objectives of this experiment were: l) to determine the 
variability of test<;>sterone release from PDS capsules into distilled 
water, and 2) to establish the influence of capsule surface area on 
the rate of release. These objectives were accomplished by measuring 
the rate of release of testosterone-tritium from capsules with the· 
following variations in external surface area; 225, 450, and 900 square 
millimeters with a thickness of 0.65 millimeter. 
Six. capsules,, of each size, were filled with testosterone-t:d tium 
(Spec·ific Activity = 1900 cpm/ug) a:r:id incubated individually in 100 ml 
of distilled water at .room temperature. Samples were withdrawn for 
scintillation counting after 6, 12, and 24 hours, thus providing a 
total of 54 ebse+-vations. The results were subjected to a 2 x 2 facto-:-
rial anal,ysis of variance (AOV) (Snedecor and Cochran, 1967). When the 
AOV revealed significant variation, the differences in tre~tment means 
were detected by Duncan's Multiple Range Test (Steel and TG>rrie, 1960). 
Experime21t 2: The Ef.fect of Capsular ·Dimensions on the Concentration 
of .Tritium in the Peripheral Plasma .of Male Rabbits . 
The relationship of c~psule surface area to the level of tritium 
in the peripheral plasma of intact male rabbits containing subcutaneously 
placed testosterone-tritium filled capsules (SA= 1900 cpm/ug) was de-
termined. The determination was made by measuring the appearance of 
tritium from testosterone-tritium filled .PDS capsules with external 
surface areas of 225, 450, and 900 square millimeters and wall thick-
ness of 0.65 millimeter. Each of the 3 capsule sizes were implanted 
subcutaneously into a.total of 21 animals (7 replicates per dimension) 
and the co.ncentration .of tritiUIQ. in a sample of peripheral plasma was 
determined at weekly intervals for one through six weeks for each 
animal. The 126 observat.ions were s1.lbjected to a 2 x 2 factorial 
analysis of variance (AOV) , (Snedecor. and Cochrq.n, 19.67) . When the 
AOV revealed significant variation, the differences in treatment means 
were detected by Duncan's Multiple Range Analypis (Steel and Torrie, 
1960). 
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Experiment.3: The Effect of Subcutaneous or Intraperitoneal Placement 
of Testosterone-Tritium Filled PDS Capsules on the Concent:r:ation of. 
Tritium in Peripheral Plasma of Male Rabbits 
The appearance of tritium in. the peripheral plasma.of intact male 
rabbits containing testosterane-tritium filled capsules with external 
surface·areas of 450 and 900 square millimeters and a wall thickness 
of 0.65 millimeter.was determined, Each of the two capsule sizes were 
implanted either s1.lbcutaneously or intraperitoneally into a total of ten 
animals each (5 replicates per dimension). The concentration of tritium 
in a sample of peripheral plasma was determined at weekly intervals for 
one through six weeks for each animal. The sixty observations for each 
implantation site were subjected to a one-way analysis of variance to 
test for.significant variance due to treatment. 
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Experiment4: The Effect of Subcutaneous Testosterone Filled PDS·Im,-
plants on. Libido and Accessory Sex Organ FunctiGm of Castrate and Intact 
Male Rabbits; Sperm Production and Plasma: Testosterone Concentration o.f 
I 
'Intact· Male Rabbits 
Forty-two male rabbits were trained to ejaculate into an artificial 
vagina. Twenty-one animals were anesthetized and bilateral castration 
performed. Twenty-one of the mature males were left intact. The cas-
trate and intact.groups were divided into three experimental treatment 
groups of seven animals each. These treatemnt groups received sub-
cutaneous PDS implants as follows: 1) cholesterol filled 430 mm2 cap-
sule, 2) testosterone filled 215 mm2 capsule and 3) testosterone filled, 
430 mm2 capsule. The wall thickness of all implants was 0.245 mm. 
Blood- samples were taken at 30, 60, and 90 days post.,..implantation. 
At.70 days post-implantation sex behavior measurements were obtained; 
each animal was ejaculated using an artificial vagina, recording moun-
ting time, ejaculation time, and.seminal volume every other day for 20 
days~ At the end of the 90 day treatment period the animals were anes-
thetized; exsanguinated, euthanized and.accessory sex organs collected 
from the intact.· animals. All organs were fixed for histology except 
one testis and epididymis from each animal which was weighed, homoge-
nized in a Waring Blender, and.counts made of spermatids and sperm 
cells. 
The six treatment groups in this experiment provided data for sex 
behavior, and accessory sex organ weights and secretion of all the 
rabbits (6 x 7 = 42) ~ The experimental design provided for a 2 x 2 
factorial analysis of variance. The two factor analysis was a com-
pletely randomized design with implants designated the fixed variable 
and testes the random variable. 
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Testes weights, peripheral concentration of testosterone and daily 
sperm production were derived from the twenty-one.intact·rabbits (3 x, 
7 = 21). These results were subjected to one.,.-way analysis of variance 
to test for significant·differences due to the treatments. 
When significant differences were indicated by either method of 
analysis of variance described above the treatment means were subjected 
to Duncan's Multiple Range Test, (Steel and Torrie, 1960). 
Experiment 5: Effect of surfa:ce 'A'.rea of·Testost~one-Filled PDS Cap-
sules on Daily Sperm Productien·and·Accessory Sex Organ Weight.in In-
tact Male Rabbits 
The purpose of this experiment was to elucidate the surface area 
of a PDS testosterone implant required to render all animals azoospermic 
without . causing hypertrophy of accessory sex organs. Thirty-six in ta.ct 
male rabbits were divided into six treatment groups of six rabbits 
each. One group designated as controls received-400 nun2 cholesterol 
filled PDS implants, The five treatment groups received 100, 200, 400, 
2 800 and 1,600 nun PDS testosterone filled implants respectively. All 
PDS capsules had a wall thickness of 0.245 mm. After 3 months the rab-
bits were. sacrificed and body weight, paired testes. weight, total daily 
sperm production, seminal vesicle, prostate, vesicular and bulbo-
uretheral gland weights recorded. 
A 2 x 2 factorial analysis of variance was performedo The two 
factor analysis was a completely randomized design with implants desig-
nated the fixed variable. 
CHAPTER IV . 
RESULTS 
The primary objective of this investigation was to establish the 
size of testosterone filled Polydimethylsiloxane (PDS) capsule required 
to inhibit spermatogenesis in mature male rabbits without altering 
libido or causing accessory_ sex organ hypertrophy, 
A series of five experiments was designed to accomplish this 
objective. The_ first experiment .was to q~termine the influence of . 
surface area of PDS capsules on the rate of testosterqne-tritium re-
lease into distilled water. The results were used to predict the 
approximate dimensions of PDS testosterone filled capsules for sub-
sequent in vivo experiments. 
The second experiment was designed to determine the relationship 
of PDS capsule surface area to concentration of tritium in the periph-
eral plasma of. intact male ra.bbi ts for one to six weeks following sub-
cutaneous. implantation of testosterone-tritium filled .PDS capsules. 
The third experiment was designed to compare·peripheral plasma 
tr.:J,.tium concentration of intact male rabbits containing eithe:i::: sub-
cutaneous PDS testosterone-tritium filled capsules or intraperitoneal 
PDS testosterqne-tritium filled capsules for a forty-two day period. 
The fourth experiment was designed to determine the approximate 
dimensions of testosterone filled PDS capsules placed subcutaneously 
in castrate ma+e rabbits required to maintain peripheral plasma 
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testosterqne concentration; male sex.behavior, and.accessory sex-organ 
weight and· secretion. The subcutaneous testesterc;me filled PDS capsules 
in-intact -male.rabbits proviqed addit:i,onal results o'--the effect of 
' 
exegenous·testost;:ero:ne upon spermatogenesiso 
The:? fifth exp~ril!lent was designed to. elucidate -the surface .. area 
of testosterone filled PDS capsules required to render al.l · animals 
azoospe~ic- without causing hypertrophy of accessory sexual org.ans •. 
Expedmen:t l; .. Release . of Testosterone-Tri ti um fr.om Polydimethylsiloxane. 
(PDS) Capsules into Distilled .Water 
Plate l shows th,e testosterone-tritium filled .. capsules (SA =.1900 
cpm/ug testosterone) used to determine the release.rate.of the steroid, 
into·distj.lled. water at room,temperature. These capsules had a wall. 
thicknessof:0.65 mm anc;i 225, 450, and 900 square millimeters of sur-
face·area respectively. The dark·objects visible.in each·end ef the 
capsules are bits ef graphite that were used for identification of each 
capsule of each treatment.group. 
In vitre release of. testosterone-tritium from these capsules into 
distilled water.is shown il'l Table Io There is a ,linear inc;rease·in.the 
amount of steroid released with respect to time for each capsule size. 
ThEl, release .rate .with respect to capsule surface area, altho.ugh vari"'." 
able, indicates a _direct re].ationsh.i,.p between rate of release·and cap-
sule surface .area.. Statistical analysis indicates significant. variance 
(P<0.01) .. due to .capsules surface area and time of ,incubation. This 
cenfirms experiments reperted by Kincl et al., (1968). 
Figure l shows the results of an experiment design~d to prove that 
the passage of te·stost~_rone through the PDS meil)brane did not. alter the 
Plate 1. Polydimethylsiloxane capsules filled with tes-
tosterone-tritium, from left to right external surface 
area of 900, 450 and 225 mm2. These capsules were used 
in·experiments one, two and three, The dark objects in 
the ends of the capsules are pieces of graphite used for 









RELEASE OF TESTOSTERONE FROM POLYDIMETHYLSILOXANE CAPSUtES 
INTO DISTILLED WATER AT ROOM TEMPERATURE 
Time (hours) 
6 12 24 
20 ± 1.6a 33 ± 2.3 62 ± 4.4 
32 ± 4.1 53 ± 6.6 96 ± 7. a· 
96 ± 6.8 138 ± 9.7 212 ± 9.4 
aEach value is expressed as ug testosterone/100 ml water and represents the mean 
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Figure 1. Radiochromatographic Scan of Concurrent Thin Layer Chromatography of Tritiated 
Material Extracted from Water Bathing PDS Testosterone Capsules and Authentic 




structure of testosterone. Note that the tritium extracted .from the 
water bathing the PDS capsules has the same chromatographic mobility on .. 
thin layer chromatography (benzene:methanol, 87.5:12.5 v/v) as authen-
tic testosterone developed in adjacent lane. 
These data suggest that testosterone-tritium was released in vitro 
from PDS capsules, that t~e release rate was continuous over a 24 hour 
period and'dependent upon capsule surface area. Moreover, passage 
through PDS does not a],.ter the steroid's chromatographic mobility upon 
thin layer.chromatography. 
Experiment 2: The Eff.ect of Capsular Dimensions, on the Concentration 
of Tritium in the.Peripheral Plasma.of Male Rabbiti;; 
The testosterone-tritium filled capsules used in Experiment 1 were 
implanted subcutaneQusly into intact male rabbits. 
The results of th.is experiment seen in Table II, show a .. direct 
relationship between capsule surface area and the amount of tritium 
detectable in the peripheral plasma.over a 6 week period. Increasing 
surface-area frqm 225 mm2 ·to 900 mm2 resulted.in increased tritium con-
centration in the peripheral plasma.· The.re was a significant difference 
(:P<0.05) in the plastila triti~ concentrations et animals receiving the_ 
225 mm2 .compared to the 9of'mm2 capsules. There_ was no-significant 
difference between 225 and.450 or 450 and 900 2 mm • Moreover, there 
was no significant.difference due to time. 
These results .suggest that testosterone-tritium was released-in 
vivo ·fr0m PDS capsules and .that increasing the capsule surface area re-
sulted.in inqreasing plasma tritium concentrations. Moreover, this 








TRITIUM CONCENTRATION IN THE PERIPHERAL PLASMA OF INTACT MALE RABBITS CONTAINING 
SUBCUTANEOUSLY PLACED PDS TESTOSTERONE-TRITIUM FILLED CAPSULES 
Time· (weeks) 
1 2 3 4 5 6 7 
269 ± 12a 256 ± 56 196 ± 20 152 ± 27 162 ± 20 181 ± 31 182 ± 24 
331 ± 29 350 ± 22 307 ± 26 250 ± 30 252 ± 31 347 ± 26 277 ± 27 
797 ± 198 741 ± 89 690 ± 74 746 ± 81 723 ± 117 . 687 ± 93 661 ± 158 
aThe data is expressed as dpm tritium/ml plasma. Each value represents the mean± or standard error 
of seven rabbits. 
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Experiment 3! The Effect of. Subcutaneous or Intraperitonea1 Placement 
of Testosterone-Tritium Filled PDS Capsules on the Concentration of 
Tritium in·. Peripheral Plasma of Male Rabbits 
60 
Testosterone-tritium filled PDS capsules were placed subcutaneously 
and intraperitoneally into mature male.rabbits. Blood samples were 
collected weekly for 6 weeks i:ind the peripheral plasma tritium concen-
tration measured. The capsules used in this experiment were the same 
ones used in Experiment 2. 
The re.sults in Table III show that there was no significant dif-
ference. due to time and no significant difference in tritium .concen-
tration in peripheral plasma .of rabbits containing subcutaneous or 
intraperitonea1 .capsules. 
These results suggest the subcu'j:aneous placement of testosterone-
tritium filled.capsules provides testosterone':'"tritium release similar 
to intraperitoneal placement of capsules. Since the same capsules were 
used in experiments 2 and 3 it a],so shows that a given PDS capsule·can 
release testosterone-tritium at a relatively constant rate over a 13 · 
week period,in vivo. 
Taken together, the results have shown thattestosterone-tritium 
was released from PDS capsules in·vitro.and in vivo •. The in vivo 
testosterone-tritium release was relatively constant over a 13 week 
period assuming plasma.tritium concentration is directly related to 
testosterone releas.e rate. 
TABLE III 
TRITIUM CONCENTRATION IN THE PERIPHERAL PLASMA OF INTACT MALE RABBITS CONTAINING SUBCUTANEOUS 
OR INTRAPERITONEAL PDS TESTOSTERONE TRITIUM FILLED IMPLANTS 
Capsule Time (weeks) 
Surface Area 
(mm2) Site 1 2 3 4 5 6 
s.c. 293 ± 25a 304 ± 22 293 ± 30 305 ± 15 277 ± 37 256 ± 28 
450 
I.P. 343 ± 65 375 ± 24 326 ± 30 366 ± 46 264 ± 28 348 ± 30 
s.c. 727 ± 96 327 ± 13 708 ± 60 578 ± 24, 600 ± 13- 658 ± 64 
900 
I.P. 786 ± 94 709 ± 64 581 ± 92 523 ± 115 726 ± 117 846 ± 108 
aThe data is expressed as dpm of tritium/ml of plasma. Each value repres~nts the mean± standard 
error of seven rabbits. 
O'\ ..... 
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Experiment 4: The Effect of Subcutaneous·Testosterone Filled PDS Im"'." 
plants on Libido and.Accessory·Sex Organ Function of Castrate and Intact 
Male Rabbits; SpermProduction and,Plasma Testosterone Concentration of 
Intact.Male.Rabbits 
Experiments land 3 failed to answer two questions: 1) what size 
testosterone filled subcutaneous PDS implant is required to maintain 
libid,o and accessory sex organ weight .and secretion .at control levels 
in castrate male rabbits and 2) what size testsoterone filled sub-
cutaneous PDS implant is required to produce azoospermia_in all treated 
males without altering sexual behavior or causing accessory sex organ 
hypertrophy? 
Plate II shows typical steroid-containing PDS capsules.used in 
Experiment 4. These ca,psules had a wall thickness of 0.245 mm and.215 
and 430 square millimeters of surface area respectively. The capsules 
were implanted subc~taneously in rabbits for ninety days prior to the 
time this photograph.was made. Note the uniform density of the cho-
lesterol capsules while the capsules containing testosterone.appear to 
be only partia],ly filled. This suggests little or none of the choles-
terol diffused out of .the PDS capsules into the control rabbits in 
which they were implanted, and provides visual evidence of the ability 
of testosterone to. diffuse out of the PDS capsules. 
. . . . 2 Androgenic Effect of.215.and·430 mm Subcutaneous·Testosterone 
Implants in Castrate Male-Rabbits. This portion of-experiment 4 evalu-
ated the capacity of testosterone, chronically administered via sub-
cutaneous PDS capsules, to .maintain libido and accessory sex organ size 
and function in castrate male rabbits over a period of 90 days. 
Plate 2. Steroid,containing polydimethylsiloxane capsules 
with external ·surface areas 430, 430. and 215 mm2. These. 
capsules were used in experiment 4. Note the different 
density in the upper portion of. the testosterone c<:m-
taining capsules. This picture was made following 90 
days.subcutaneous placement in rabbits. 
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Sexual Behavior, The effect of testosterone.filled PDS implants 
on the sex behavior of castrate male ra,bbits is shown in Table IV; 
Castration for 70 days abolished sex behavior in male.rabbits (0 score) 
as expected. Implantation of-215 mrn2 testosterone PDS implants sig-
nificantly increased _the sex behaviQr score to 6.0 while those receiving 
2 
430 nun testosterone, PDS implants showed a further increase of sex be-· 
havior score to 9.8. There was no significant.difference betweel'l the 
scores of intact rabbits (8.4) and castrate rabbits which received the 
2 430 mm· testosterone PDS implant. 
The._se results suggest that the.sexual behavior of castrate.male. 
rabbits was maintained at normal levels by exogenous testosterone sup-
plied by testoster.one. filled PDS implants with a surface area of 430 mm2 
with wall. thickness of .0.245 mm. 
Accessory Sex Organ (ASO) Weight. The results in Table V show 
the effect of subcutaneous testosterone filled PDS implants on the 
weight ·.of . seminal vesicles, prostate, vesicular and bulbouretheral 
glands of castrate male rabbits. 
The removal of testicular androgen, via castration, resulted in a 
marked decrease in weight of all the accessory sex organs mentioned 
above. 
Accessory sex organ weights of .castrate .rabbits receiving testos-
terone PDS implants showed response proportionate to the surface area 
of testoste.rone PDS capsules implanted. · Rabbits receiving the 215 mm2 
implants had ASO weights 58, 60, 67 and 68 percent of that observed in 
intact·rabbits. Accessory sex organ weights of rabbits receiving 430 mm2 
testosterone PDS implants were not significantly different from the 
intact rabbits. 
TABLE IV 
EFFECT OF PDS TESTOSTERONE IMPLANTS ON THE SEX BEHAVIOR OF CASTRATE MALE RABBITS 
Contents and Size Sex Behavior Score 
of Implants Testes (0-10) 
Cholesterol - o.oa 
430 mm2 
Cholesterol - 6.0 ± 1.7 
215 mm2 
Testosterone - 9.8 ± 0.13 
430 mm2 
Testosterone + 8.4 ± 0.85 
430 nun2 
aEach value represents the mean± the standard error of seven rabbits following sub-
cutaneous placement for ninety days. 
O"I 
O"I 
Contents and Size 










EFFECT OF PDS TESTOSTERONE IMPLANTS ON THE WEIGHTS_ OF 
ACCESSORY SEX ORGANS OF CASTRATE -MALE. RABBITS 
Org:an Weig:hts 
Seminal Prostate Vesicular 
Testes Vesicles Gland Gland 
- 135 ± lOa 113 ± 20 129 ± 29 
+ 508 ± 70 693 ± 60 807 ± 70 
- 297 ± 40 415 ± 50 539 ± 60 
- 476 ± 90 572 ± 40 778 ± 90 
Bulbourethral 
Gland 
216 ± so 
622 ± 90 
424 ± 30 
616 ± 60 
aEach value represents the mean± the standard error of seven rabbits following subcutaneous 




These results confirm the fact -.that accessory sex organ weight is 
dependent ·upon -testosterone (Mann et aL, 1949). It alsq suggests that 
the 430 mm2 tes_tosterone implant releases adequate amounts of testos-
terone to maintain ASO weight simila:i:: to control rabbits. 
Accessory Sex Organ Secretion. That accessory sex organ secretion 
is maintained by subcutaneeus PDS testosterone implants-is shown in 
Table VI. Castration for 90.days ·reduces seminal plasma volume, 
citric acid and ,fructose-cencentration te zero. The castrate male rab-
bits which received 215 mm2 PDS.testosterone implants produced seminal 
plasma ·with significantly (P~0.05) lower citric acid and fructose con"." 
centrations than the castrate males which con~ained 430 mm2 -PDS tes-
to_sterone. implants -or the intacct. males which con_tained cholesterol 
filled implants. There was no significant difference in the seminal 
plasma volurile 7 citric acid or fructose concentrations of the_castrate 
males receiving 430 mm2 PDS testosterone implants and the intact males 
receiving cholesterol PDS implants. 
These results confirm that the 430 mm2 testosterone.PDS implant 
releases adequate·amounts of testsoterqne to_ maintain ASO weight and 
secretion. 
Antispermatege.n.:uc. ·Effect ef .·.Testc:>sterene -PDS Implants in Intact 
Male-Rabbits._ The second part of experiment 4 involved_an evaluation 
of the ability ef testosterone, administered via subcutaneous PDS cap-
sules; to inhibit spermatogenesis in intact male rabbits without 
changing libido er_producing-acGessory sex-ergan hypertr0phy. 
This evaluation was,based on changes in testicular morphology.and 
spermatozoa production, sex behavior, ac·cessory sex organ size and 
TABLE VI . 
EFFECT OF PDS TESTOSTERONE IMPLANTS ON SECRETORY FUNCTION OF 
ACCESSORY SEX ORGANS OF CASTRATE MALE RABBITS 
Seminal Plasma 
Contents and Size Citric Acid 
of Implants Volume Concentration 
Testes lml} (mg/ml) 
Cholesterol - o.o o.o 
430 mm-2 
Cholesterol + 0.43 ± 0.08 1.73 ± 0.30 
430 nun2 
Testosterone - 0.39 ± o.1sa 0.62 ± 0.23 
215 mm2 






2.30 ± 0.34 
0.93 ± 0.14 
2.46 ± 0.52 
aEach value represents the mean± the SE of seven rabbits following subcutaneous placement of 




function and peripheral plasma testosterone,concentratio~. 
Testicular Function. Spermatogenic function was evaluated by 
testing the effect of PDS testosterone capsules on testicular histology, 
size and spermatozoan production. 
Testicular Histology. Plate 3 is a photomicrograph of a.repre-
sentative field,of testis sections.from rabbits receiving cholesterol 
PDS capsules. Note the presence of_mature spermatids ready to detach 
from germinal eptihelium becom.:j.ng free testicular spermatozoa.in the 
tubule lumen. 
Plate 4 shows a representative field of testis sections from rab-
bits receiving the 430 mm2 PDS testosterone implants. Note the reduced 
diame.ter .and marked histological changes in the seminiferous tubules. 
Most of the inhibited tubules are devoid of all spermatids, with a .re-
duced.number of pachtene spermatooytes and secondary spermatocytes. 
Perusal of the h~stological sections leads one to believe that 
the 430 mm2 subcutaneous testosterone implants seriously impair, 
spermatogenic function of rabbit testes. 
Testis Size. The results in Table VII show that paired testis 
weights of>rabbits receiving 215 mm2 PDS testosterone implants for-
ninety days·were significantly (P<0.01) reduced from paired testis 
weights. of those.receiving cholesterol implants. When the.capsule 
size was increased to 430 mm2 the testes weight was reduced even fur-
ther _(6.14 g to 1.56 g). 
Spermatozoa Production. Rabbits receiving the 215 mm2 PDS tes-
tosterone implants showed a marked reduction (P<0.01) in daily sperm 
Plate 3o A photomicrea>graph of a cross-section of semi"". 
niferous tubules from a mature rabbit that received a 
430 mm2 PDS cholesterol implant'for 90 days. Note.the 
size of the tubule in.relation to field of view, anq. 
the presence of mature spermatids. Magnification 250X. 
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Plate 4. A phot<Dmicrograph.of a seminiferous tubule 
cross-section fr(;)m a mature rabbit that received a 
430 mrn.2 PDS testosterone implant. for 90 days" Note 
the size of the tubules in relation to the field of 
view, the absence of spermatidsc Magnification.250X. 
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TABLE VII 
EFFECT OF PDS TESTOSTERONE IMPLANTS ON TESTES FUNCTION 
Size of Testes and s2ermatozoa Production 
Contents and Size Paired Testes Weight Total Daily Sperm 
of Implants (g) Production (x106) 
Cholesterol 6.14 ± 0.61a 214.9 ± 24.4 
430 mm2 
Testosterone 3.62 ± 0.38 123.5 ± 29.1 
215 mrn2 
Testosterone 1.56 ± 0.36 16.0 ± 14.9 
430 mrn2 
aEach value represents the mean± the SE of seven rabbits following sub-
cutaneous placement of the implants for ninety days. 
-.J 
ll1 
produ9tion whe~ compared to control ra~bits. Five of seven rabbits 
which received the430 mm2 PDS testosterone implant had sperm.counts 
of zero.. The 16 million total daily sperm production shown in Table 
VII resulted from impaired spermatozoa production by two rabbits 
in the treatment group. 
These results show that the 430 mm2 testosterone filled PDS cap-
sules implanted subcutaneously for 90 days in mature male rabbits 
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will .completely inhibit spe:pnatozoa·production in five .of seven rabbits. 
Se.xual Behavior 
That exogenous testosterone administered continuously via .PDS 
testosterone implants in amounts sufficient to .inhibit spermatogenesis 
in five of seven rabbits will not significantl.y change sexual behavior 
is shown in Table VIII. Although the intact·ma].e rabbits. receiving 
430 mm2 PDS testosterone capsules consistently scored the highest 
sexual behavior, there was no significant difference. in scores of in-
tact·males receiving cholesterol f:i,lled, ·215 mm2 or 430 mm2 , testos-
terone filled .PDS capsules. 
Accessory·sex.Organ.Weight 
The .. data. in Table IX show the .. effect of exogenous testosterone, · 
administered via PDS.capsules for 90 days, en the weight of seminal 
ves.icles, prostate, vesicular and bulbouretheral glands in intact. 
rabbits •. 
The heaviest ac.cessory.sex organs were those of·the cholesterol 
implanted contr<.>l rabbits. None of. the an:Lma],.s receiving te.stosterone 
PDS implants had accessory sex organs which exhibited hypertrophy. 
TABLE VIII 
EFFECT OF PDS TESTOSTERONE IMPLANTS IN SEXUAL 
BEHAVIOR OF INTACT MALE RABBITS 
Contents and Size Sex Behavior Score 
of Implants (0-10) 
Cholesterol 8.65.± 0.85a 
430 mm2 
Testosterone 8.07 ± 0.97 
215 mm2 
Testosterone 9.90 ± 0.03 
430 mm2 
aEach value represents the mean± the SE of seven rabbits following sub-
cutaneous placement of the implants for ninety days. 
-.J 
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EFFECT OF- PDS-TESTOSTERONE IMPLANTS ON WEIGHTS OF 
ACCESSORY SEX ORGANS OF INTACT MALE RABBITS 
organ Weights (mg) 
Seminal Vesicular Prostate 
Vesicles Gland Gland 
508 ± 1oa 807 ± 70 693 ± 60 
358 ± 30 762 ± 80 458 ± 30 
398 ± 30 804 ± 80 510 ± 40 
Bulbourethral 
Gland 
622 ± 90 
527 ± 20 
608 ± 70 
aEach value represents the mean± the SE of seven rabbits following subcutaneous placement of 




Mqreover, there were no significant differences in AS.O weights between .. 
any treatment groups. 
These ._results suggest the 215 and 430 mm2 testosterone. filled PDS 
capsules will not cause accessory sex organ hypertrophy when placed.in 
intact .male .. rabbits fqr 90 days. 
Accei;soxy Sex Organ . Sec~etion 
The result.sin Table X show that subcutaneous implantation of .tes-
tosterone PDS·capsules for 90 days in intact male rabbits did not 
change-the secretory.function of the accessory sex organs as mea:;;ured 
by seminal volume, citric acid ccncentration and fructose concentration 
of the seminal plasma. This suggests that the sizes of PDS testosterone. 
capsules used-in this experiment will not alter.the function of acces-
sGry sex·ergans.when placed subcutaneously for 90 days in intact 
male rabbits. 
Peripheral Plasma. Testosterone Concentration· 
A basic thesis ef -this investigation was-that it is possible to 
administer exogenous testosterone in dqsages that inhibit hypophyseial 
gona<iotr9phic hormone, release, .resulting in decreased testicular· tes-
tostercme secretion and sperm production. Theoretically the exogenous . 
testeste;i::one could maintain peripheral te_stosterone at concentrati0ns 
sufficient to maintain libidowitllout.causing accessory sex organ 
hypertrophy. 
The results in TablE;i XI show that peripheral plasma testosterone 
concentration ef intact male.· rabbits containing P:DS. testosterone . 
implants is not significantly different that the concentration of 
testosterone in the- pel;'ipheral plasma of rabbits implanted with PDS 
choles.terel capsules • 
TABLE X 
EFFECT OF PDS TESTOSTERONE IMPLANTS ON SECRE:TORY FUNCTION OF· 
ACCESSORY SEX ORGANS OF INTACT MALE RABBITS 
Seminal Plasma 
Citric Acid 
Contents and Size Volwne Concentration 
of Implant {ml) (mg/ml) 
Cholesterol 0.60 ± 0.08 1. 73 ± 0.30 
430 mm2 
Testosterone 0.52 ± 0.04 1.64 ± 0.24 
215 mm2 
Testosterone 0.63 ± 0.04 1.62 ± 0.17 




2.30 ± 0.34 
2.37 ± 0.30 
1. 74 ± 0.09 




EFFECT OF PDS TESTOSTERONE IMPLANTS ON PERIPHERAL PLASMA 
TESTOSTERONE CONCENTRATION IN INTACT MALE RABBITS 
Contents and Size Peripheral Plasma Testosterone 
of Implants ng/ml 
Cholesterol 2.1.4 ± o.15a 
430 mm2 
Testosterone 1.45 ± 0.30 
215 mm2 
Testoste5one 1.66 ± 0.13 
430 mm 
aEach value represents the mean± the SE of seven rabbits following subcutaneous place-




These results show that testosterone was maintained at a constant-
level in intact rabbits from tWG sources (PDS testosterone.implants and 
testes) and suggests that the_testicular contribution was decreased in. 
animals receiving the 215 and 430 mm2 PDS testosterone implants. 
2 The fact that only fiv:e of seven rabbits receiving the .430 mm 
PDS testosterone implants were azoospermic suggests that larger im-
plants are·required to,completely inhibit spermatogenesis in rabbits. 
Experiment 5: Effect of .surface Area of Testosterone Filled PDS . 
Capsules on Daily Sperm .:Production and Accessory. Sex Organ Weight -in 
Intact .Male .Rabp,its 
The objective of this experiment was to elucidate the surface 
area of PDS testosterone ·. implant necessary to render all animals 
azoGspermic without causing hypertrophy of accessory sex organs. 
Effect of PDS Testoster0ne 1 Implants on Testes Function. The data. 
in Table XII show the effect of testosterone filled PDS implants on 
testicular function. 
Testis Size. The! results in Table XII-show that paired testis 
weights were significantly dec.reased (P<0.01) in rabbits receiving tes-
2 tosterone PDS implants with 400, 800, _Qr 1600 mm surface.area, but 
that there was .. no significant decrease in rabbits receiving testos-
2 terG1ne PDS implants with surface area of.100 or 200 mm. 
Spermatozoa. P:rodue:::_tion. That tetal daily sperm production was 
dec.reased significantly (P<O. 01) with increased surface area ot tes-
tosterone·PDS implants is also shown.in Table XII. Animals receiving 
the 800 I!Utl2 testosterone.PDS im~lants were all azoospermic. 
TABLE XII 
EFFECT OF PDS TESTOSTERONE IMPLANTS ON TESTES FUNCTION OF RABBITS 
Size of Testes and SEermatozoa Production 
Content and Size Paired Testes Total Daily Sperm 
of Implants Weight (g) Production (xl06) 
Cholesterol 4.89 ± 0.58 210.0 ± 38.4 
400 mm2 




Testosterone 4.53 ± 0.62 154.0 ± 36.2 
200 mm2 
Testosterone 1.91 ± 0.62 34.0 ± 19.0 
400 mm2 
Testoste2one 0.65 ± 0.11 0.0 ± 0.0 
BOO mm 
Testosterone 1.00 ± 1.07 7.0 ± 4.2 
1600 mm2 
aEach value represents the mean± the standard error of six rabbits folldwing subcutaneous 




Effect of PDS Testosterone .Implants on .. the Weights-of Accessory. 
Sex ·Organs. of Intac:t;. Rabbi ts. The resul.ts in Table XIII show that· 
seminal vesicle, prostate., ve~icular and bulbou:r;:etheral gland W'eights 
were not significantly altez:ed due to surface a1;ea 0f PDS .testosterone 
. 2 
implants · until the surface a:rea w~s ·. increased to !Gao :mm • 
Taken together the results of·experiment.5 suggest that spermato~ 
genesis ,can be inhibit~d in male, rabbits without ca~sing accessory sex. 
organ hypertr-ophy. 













EFFECT OF PDS TESTOSTERONE IMPLANTS ON THE WEIGHTS 
OF ACCESSORY SEX ORGANS OF INTACT RABBITS 
Or~an Weishts (ms) 
Seminal Prostate Vesicular 
Vesicles Gland Gland 
312 ± 47a 611 ± 68 642 ± 60 
306 ± 33 741 ± 163 788 ± 77 
388 ± 47 638 ± 57 652 ± 93 
311 ± 47 479 ± 41 565 ± 68 
1015 ± 16 661 ± 36 955 ± 112 
Bulbourethral 
Gland 
663 ± 173 
620 ±- 51 
569 ± 72 
484 ± 54 
888 ± 84 
aEach value represents the mean± the standard error of six rabbits following subcutaneous 





Numerous investigations have shown that steroidal hormones, in-
clt;iding testoste.rone pass thrqugh polydimethylsiloxane membranes at 
predictable rates {Dziuk and Cook, 1966; Kincl et aL, 1968; Moon and 
Bunge, 1968; Chang and Kincl, 1970; Hwang et al., 1970). However, 
these investigators did not evaluate the rate of testosterone release. 
critically enough to allow us to ascertain.the rates of testosterone 
release requir.ed for our experiments. 
Kincl-~al., (1968) reported that testosterone was released from 
PDS capsules with wall ·· thickness of O .1 mm at the rate o:f; 317 ug/24 
hrs/100 mm2 into di.stilled water. Extrapolation of results obtained 
with.the 900 mm2 , 0.65 mm thick, PDS testosterone capsules shown in 
Table I of this repo~t, indicates a testosterone release rate of 156 ug/ 
24 hrs/100 mm2 for a, 0 .1 mm PDS membrane o. These release rates obtained 
by the two -laboratories are of the Sa.I(le order of magni tuc;l.e and the._ 
slight differe.nce .can probably be explaim\!d on the basis· of different 
lots of Silastic tubing · (Hwang et al.,· 1970) or different methoq.s of• 
pakc,tng the Silastic tubing wi-t:h crystalline testosterone. Our ex-
perience·indicat;es that the elastic properties of Silastic tubing 
allow distensien Qf capsule walls during filling wi tn a crystalline_ 
material and that sharp ster.oid crystals. lacerate tubing walls if the 
crystals.are packed into the tubing with excessive force. 
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The fact.that our results prqve that there is a direct relation-
ship between capsule surface area al').d rate of.testosterone,movement out 
of PDS ·.capsules in ·vitro, suggests that different <iosages of testos-
terone could be administered to an animal by varying the surface area 
of ,the PDS me]11braI1e. 
The fact·that the tritium extracted from the.distilled water 
bathing the. testosterone•tritium .fille.d PDS capsules has the same 
chromatographic mobility as ·.authentic testosterene (Figure l) is preof 
that. testoste.rone passes threugh PDS membranes unchanged. This is 
important if we are to use testesterone filled PDS·capsules to inhibit 
spermategenesis in intact. rabbits·. However, these experiments de not 
prove that testesterone will be released.in sufficient quantities to 
inhibit spermatogenesis in .. rabbits. Moreover, they do not prove that 
there is a relationship of capsule surface area to testosterone re-
lease from subcutaneous testosterone PDS implants. 
Moon. and.Bunge (1968) reported that Silastic capsules containing 
testosterone release sufficient quantities of testosterone to maintain. 
the growth rate of accessory.sex organs of castrate rats for sixteen 
weeks, These.results although encouraging could not be used.to sup-
port our experiments since Moon and Bunge used rats, since no quan-
titative rate of steroid release was determined and since all· the. rats 
receiving Silastic testosterone capsules were castrated. 
It wa~ postulated that monitering the.tritium levels in peripheral 
plasma ef rabbits contc3.ining PDS testosterone implants would be a 
simple and effective means.to determine the relative rate of .testos-
terone release.from PDS capsules ef various,dimens±e??,s in vivo. 
The author realizes that test0sterone.in the circulating .blood of 
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animals is rapidly metabolized (Leach et al., 1956; Rhynes, 1971). The 
results in Table XIV (Appendix A) show that testosterone~tritium repre-
sents only l to 2 percent of .the total plasma-tritium present in rabbits 
receiving sul::icutaneous te$tosterone-tritium PDS implantso However, 
since we are . interested only in· the releas.e of tritium from the PDS 
capsule$ the important question is whether-or not there is a relat~on-
ship between peripheral plasma tritium concentration and capsule di-
mension after a period of several weekso 
Results of experiment 2 (Table II) show that increasing PDS tes-
toste.rone implant size. from 225 mm2 to 900 mm2 in intact ·male rabbits 
produced a significant (P>0.05) inc:t;"ease in peripheral. plasma tritium 
concentration. Moreover, the relationship existed throughout the 7 
wee~ experimental period without a significant decrease ·in plasma 
tritium concentration due to time. Taken together these results sug-
gested that steroid release was related to surface area of the capsule 
and was contim,ieus ·.over the 7 week period. 
Experiment 3 was designed to answer the question of :whether the 
site of .capsule implantation influences rate of testesterone-tritium 
passage through the PDS capsule wall. The subcutaneous·site was chosen 
because it provides-a limited abse:i;-bing surface of tissue while the 
peritoneal cavity offers a large absorbing surface.from which drugs 
enter the circulation rapidly (Fingl and Wooc;ibury, 1970). The com-
parison·of release rate versus site of implantation was not intended. to 
provide evidence to select the most efficacious.site for PDS testos-
terone implants, but to demonstrate.that the factor limiting testes-
terone-tritium release from subcutaneous PDS implants was the surface 
area of the capsule. The intraperitoneal site of implantation was not 
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used in.experiments where we attempted to inhibit·spermategenesis since 
absorptien of-drugs from the.peritoneal cavity takes place primarily 
through the_ visceral rather than the pa~eital peritoneum or-lymphatics 
(Leach ·et alq 1956; Fingl and, Wooq.bury, ·1970) resulting in rapid dr_ug 
metabqlis~. 
No significant difference in plasma tritium concentration was, 
found. in rabbits containing subcutaneous.or ·intraperitoneal testosterone-
tritium PDS _capsl.l,les (Table III). The results.of experiment 3 show 
(Taple III) that-there is nQ significant-difference in.plasma tritium 
concentration frCllm a given- capsule size, -with time.. Since the same 
PDS , testosterone. _capsules were used . in -experiments 2 and 3, these .re-
sults .suggest that a.continuous release of testosterone-triti:um was 
achieved for th·irteel'). weeks. 
Taken .together the results of experiments 1; 2, an.d 3 have shown 
that -testGsterone:is re~eased from PDS capsules in vi-tro. and in vivo,__ 
that releas_e · is centinuous fer up te 13 weeks and that the rate ·of ·re-
lease _in·these experiments was influenced primarily by the external 
surface area of·the PDS capsules. This information .along with infer-
matien frem experiments ;reperted :by Kincl il al., (1968) was used 
to ;calc~lat1:1 the. capsl;lle dimensions required for subseque:Qt in .vivo_. 
' -----
experiments. · Sev_eral que~tions remain unanswer1:1d. · 
What size of. PDS testeste~one implant is required to maintain male 
sexual behavio:r:: at control levels in castrate male-rabbits? Caf:!tration 
for 70 to 90 days abolished sexual behavior_in male·rabbits (Table IV) 
measured by.each.rabbit's proficiency to mount; thrust, ·and/or ejacu-
late. into an,.artificial vagina within a specified time. Rabbits re-
ceivi:q.g 430 mm2 ·(Q,245 mm wall thickness) PDS testosterone implant!:! had 
sexual behavior .scores that were not significantl.y different from the· 
scqres of intact controls.receiving cholesterol implants (Table IV), 
These results indicated that enough testosterone was released from the 
430 mm2 capsules to maintain libido of castrate male rabbits at con-
trel levels. 
2 
The fact·that the 215 mm capsules only partially re~ 
stored libido of castrate rabbits suppqrts the contention that the 
amount of .testosterone released.from PDS capsules is dependent upon 
surface areao These results compare favorably with results reported 
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by Macmillan .and co.-workers (1969) , who reported restoraticm of normal 
libido in castrate·male rabbits with 0.5 mg of:testoste~one propionate· 
administered subcutaneously in corn oil every second-dayo 
What size of PDS testosterone implant is required to maintain 
accessory sex organ size and secretion at control levels in castrate 
rabbits? Castration resulted.in a marke~ decrease in weight of seminal 
vesicles, prostate, vesicular and bulbourethral glands o:l; rabbits 
( abl ) bb . · · 430 mm2 ' h d T .e V . Ra its receiving PDS testosterone implants a . 
accessory sex organ weights thatr were not significantly different from 
the accessory sex organ weights of intact controls recE;livi:ng chelesterol 
implants (Tab.le V) • These results indicated that enough testosterone 
was-released from the 430 mm2 capsules to maintain accessory sex organ, 
weights. of castrate male rabbits at ·control levels, moreover). the. 
weights of accessory glands of the rabbits conta,ining 430 mm2 testes-
terone implants did not exceed the . accessory gland weights. of tl:le in-
tact control rabbits. Further evidence of the dependence of.sterqid 
release rate on capsule surface area is.provided-since rabbits receiving 
2 the 215 mm. testosterone capsules had accessory sex organ weights sig-
nificantly lower ... than those of the intact.control rabbits and rabbits 
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2 
receiving 430 mm testosterone capsules o These results are. in agree-
ment with those of Price (1947) confirming that accessory sex organ 
weights a:i:;-e regulated by the amount of .testosterone available. 
The effect of testosterone on the maintenance of size and function 
of seminal vesicles, prostate, vesicular and bulbourethr~l glands is 
well established (Mann, 1956; Price and .Williams-Ashman, 1961; Mac.,-. 
millan et: al., 1969). That the secretion of both citric acid and fruc-
tose by the.male accessory sex organs occurs only in the presence of 
the male ·sex hormone.and is subject to fluctuations in response to de-
creased. or increased ac.ti vi ty o:e testosterone in the male is _documen-
ted (Mann et al., 1949). Testosterone.supplied to castrate male 
rabbits via.430 mm2 PDS testosterone implants maintained the citric 
acid and fructose c~ncentrations of seminal plasma to the levels of 
intact control rabbits while the amount of testosterone supplied to 
2 rabbits via 215 mm capsules did not (Tab.le VI) o Thus taken together 
the results of experiment 4 have shown, that testosterone .. from . testes of 
male rabbits can be replaced via 430 mm2 testosterone filled PDS 
capsules pla,ced.subcutaneouslyo These observations.are interpreted to 
mean that the amount of testosterone released from the 430 mm2 capsule 
is approximately the same as that amount reaching the systemic circu-
lation in intact male rabbits. 
There may be a different level of testos.terone required by in-
dividual target organs including the hypothalamus, accessory sex organs 
and germinal epithelium. Albert (1961) and Woods and Simpson (1961) 
suggest .that less testosterone.is required for maintenance of accessory 
sex organs than is required for germinal epithelium to complete sperma-
togenesis. Dav.idson (1967) concluded that the hypothalamus contains 
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receptors sensitive to high or low circulating levels of testosterone, 
with high levels of testosterone responsible for diminished release.of 
gonadotrQphic hormones from the pituitary. 
2 The results of this study suggest ·that a 430 mm PDS testosterone· 
implant may rel.ease adequate ameunts · of ·testosterone· to maintain brain 
and.accessory sex organ function in male r~bbits, inhibit release of 
ax:iterior pituitary (JJOnac;lotrophins and red.uce high local levels of·. en-
degenous te.stosterone in the. testes resulting in aspe.:rma togenesis. 
Therefore, the next series ef questions to be -answered dealt. with the 
.antispern:ta,togenic effect of PDS testosterone. implants in intact male 
rabbits. 
What effect does PDS testosterone implant~ have on the morphology. 
of germinal epithelium, size of the testes and total.daily spe:I;lll pro-
duc,tion of raj:)bits? Rabbits containing 430 mm2 testesterone · capsules 
exhibited· greater reduction in germinal cells (Plate.IV) and testic-glar 
'tfeight .(Table VII) than. rabbits containing 215 mm2 testosterone cap-
s~les •. The germinal· .epitl)elial changes were very si:m.i,lar .to those ob-
served in hypophysectomized rats by Ludwig (1950) and rabbits reported 
by Albert (1961). Rabbits containing 430 mm2 testosterone capsules 
showed the largest drop in sperm production. Five of seven rabbits re-
ceiving 430 mm2 capsule~ had no detectable spermatozoa in tissue home-
genates of testicular parenchyma after the capsules had been in place 
for 90 days. The 16 million daily sperm productiol) shown in Table 
VII·.resulted .from two r~bd.ts with impaired spermat.ozoa producti.on. 
The·re. are . no· published reports of research .to · compare with theli?e ·findings. 
We were aware·of the fact that if this method were to be an. effec-
tive male contraceptive it ,rnu~t cause azoospe:onia without. alte.ring 
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sexual. behavier and accessory sex.organ morphol0gy and secretion.· 
Male sexual behavior was maintained at control levels by 215 and 
430 mm2 testosterone· implants (Table VIII}, in the.se same intact rabbits. 
Accessory sex organ -weights and secretory activity were not-in excess 
of the accessory sex. gland weights and secretory activity of intact 
control rabbits. The fact that there was no significant difference 
in.peripheral plasma testosteronecencentration of rabbits receiving 
PDS cholesterol implants and those rece_iving 215 or 430 mm2 testos-
terone implants supports, these results o 
The fact·that testosterone was maintained at the same level in 
intact male rabbits froflt two sG>urces (PDS testosterone implants and 
testes) suggests that the testicu~ar contribution was decreased in 
2 
animals receiving the 215 and 430 mm PDS testesterone implants, re""' 
spec ti vely. Thi.s hypo th es is is supported by the fact. that sperm pre~ 
2 
duction and testis size in animals receiving 430 mm PDS testesterone. 
2 
implants was significantly smaller than those receiving 215 mm tes-
tosterene-implants, An explanation for these results is that the 
hypophyseal production of interstitial cell stimulating ho:rnione was 
reduced in animal,s receiving 215 mm2 implants and.further reducE!d·in. 
animals receiving 430 mm2 implants, resulting in decreased testesterene 
secretion by Ley.dig cells and.reduced spermatogenesis in both groups. 
2 The faqt that only 5 of 7 rabbits receiving the 430 mm· testes-
terone. capsules .were azoospermic suggests that larger implants are re-
quireq to completely inhibit spermatogenesis in all rabbits. Therefore, 
experiment 5 was ,designed to answer. the ques.tion of what size PDS tes"" 
tosterone implant . weuld result in zero sperm production in 100% of .. 
the experimental rabbits without increasing accessory.sex ergan weights .. 
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Rabbits receiving 800 mm2 (wall thickness O. 245 mm) testosterone filled. 
capsules had zero sperm production at90 days post-implantation (Table 
XII) • Moreover, seminal vesicle, prostate; vesic\llar .and bulbourethral 
gland weights were not altered significantly in rabbits receiving 800 mm2 
Pii>S testosterone capsules. However, the fact that rabbits receiving· 
capsules with a total.of 1600 mm2 had increased accessory sex organ 
weights shows the animal model selected for this study is sensitive to 
the.andrGgenic effect of excessive de,5ages of testosterone. 
This method of inhibition of spermatogenesis meets certain.of the 
criteria for a systemic contraceptive agent listed in Chapter II. In 
rabbits the testosterone filled PDS implants have been shewn to be 
100% effective in producing aspermatogenesis, they are not deleterious 
to the acoessory sex organs or -male sexual behavior of recipient rab-
bi.ts and a simple method for chronic administration of a readily avail-
ab.le, economically produced material has been demonstrated. The 
specific criteria not investigated during this study are.whether the. 
antispermatogen_ic ef:£ect in rabbits is. reversible· thus what, if any, 
deleter:i,ous effects ma,y be .produced.in offspring of recipients of PDS 
testosterone implants. Although extensive investigation remains to 
be performed in other species before intelligent predictions can.be 
made for the use of PDS testosterone implants in humans as a male 
contraceptive, the present study is .a significant·contribution to the 
' 
quest for an efficient, safe, systemic male contraceptive. 
CHAPTER VI 
SUMMARY AND CONCLUSIONS 
Apprel,i)riate, androgen therapy (Heller .~·al., 1950) results in. 
azeospermia in_ man·that is reversible.uponwithdrawal·of .the hormonal 
steroid. It_ has been impri;ictical to investigate the potential of this 
COl!cept as a .male :contz.:aceptive tec}?.nique because of the -difficulty 
in sustaining specific conce.ntratiens of androgens in peripheral bleod 
over prolonged time periods. A particularly promising approach to 
administering androgens at controlle4 rates may. invelve subcu'!;:aneous, 
implantation of androgen -filled polyciimethylsiloxane capsules. Nu-
merous investigations have.shown that andx'ogens and other steroidal 
hormo~es pass through these polymers at predictable rates (Dziuk and 
Cook, 1~66; Kine],, et!!_., 1968; Moon and.Bunge, 1968; and Hwang ~al., 
1970). 
Experiments have been completed demonstrat;:ing that :testoste:rene-
tritium passses ou~ of polydimethylsilexane capsules suspended in water, 
that-the tr,itiated.material released into-water has the same chroma-
tographic mobil:j.ty a~ authentic testosterene when subject.ed to thin-
layer chromategraphy, that release rate into water {ug/24 heurs) is· 
dependent upon capsule su~face area, .that release fz.:om subcutaneous 
implants depends upon -surface area and.that.release in vivo is censtant 
over 3 months. 
Castration abolished libido and cau$ed aacessory-sex o~gan-atrophy 
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in male rabbi ts. In centrast, lib-id,e and acc~ssery sex organ weight-. 
and secretien in castrate rabbits receiving• s~cutaneeus teS!_testerone · 
filled .implants (430 m1n2) were ident.ical to intact rabbits recej,.ving 
subcutaneous ch:elesterel implants for 3-menths. Intac~ rabbits 
cont~ining subcutaneeus testestero~e filled .implants·. (430 mm2) far 
3 ·men~.s were similar to centrol rabbits in sex behavior score, con-
centratiQnn of testosterone in peripheral bloed, accessory sex ergan-
weight·.and seminal-fructose and citric acid concentration. In con~ 
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tra~t, paired testis weights and daily sperm produ~tien were sig-
nificantly reduced in rabbits receiving the 430 mm2 subcutaneeus im-
plants. However, only fi:ve of seven rabbits in this latter greup were 
azciespermic. · Subsequent .. experiments shewe4. that 800 mm2 subcutaneous 
testosterene filled polydimethylsilexane implants resulted in al!'ioesper-
mia in all. animals witho~t causing accessor.y sex organ hypertrophy. 
In conclusie.n the results ef ·experiments 1-3 proved that· 
testosterone .... tr.i tium passes·. thr-ough .. polydimethylsiloxane capsules 
suspended ;i.n water, that the tritiated mate:r;:ial :released into water 
hiiat the same.chromategraphic mobility· as authentic testosterone when 
sub.ject.ed tCi> thi~-layer chremategraphy, that release rate into wate_r is 
dependent upon capsules sur(ace,area, that release.from capsules .im-
plante.d either subcutanE;!ously or -.intraperi toneally is similar and 
dependent upon .cap_sule surface. area. 
The·.resuJ.ts o:I; experiment four al)d five preved-_that subcutaneous, 
pelydimethyls.ilo~ane testG>stercme._implants totaling 800 mm2 of surfa_ce 
area releas.es adequate ~cunts of _testesterone ._to result _in azoospermia 
in all of .the experimental animal.s·witheut. causing hypertrophy of ac-
cessory sex organs. 
These results .suggest that the appropriate sized testosterone 
polydimethylsiloxane implant in the male·rabbit will cause sterili:1:Y· 
for at lea!:!t·3 months without causing accessory sex organ hypertrophy. 
Whether this concept will prqve ef:fective in the human remains to be 
determined •. 
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DISTRIBUTION OF TRITIUM IN THE PERIPHERAL PLASMA OF INTACT MALE RABBITS 
CONTAINING SUBCUTANEOUS PDS TESTOSTERONE-TRITIUM FILLED IMPLANTSl 
Total Tritium in Total Tritium in Testosterone 
Plasma Sample Dichloromethane Extract Tritium 
dpm/sam.ple dpm/sample % of total tritium dpm/sample % of total tritium. 
5733 108 2 109 1.9 
13514 275 2 160 1.2 
14384 750 5.2 187 1.3 
1The plasma from the 5th week of blood collection reported in Table II was pooled. A 1 ml 
aliquot was removed from pooled plasma and counted in Aquasol (New Englal'.ld Nuclear). The remainder 
of the plasma pool was extracted three times with 2.5 volumes of dichloromethane. The aliquot was 
removed and counted in Aquasol as above. The remainder was concentrated under nitrogen, developed 
in thin layer chromatography system benzene:ethyl acetate (110:.100) and the area corresponding chro-
matographically to testosterone eluted and counted in Aquasol. All counts were corrected for quench-







ANALYSIS OF VARIANCEl OF TESTOSTERONE CONCENTRATION IN DISTILLED 
WATER BATHING PDS2 TESTOSTERONE CAPSULES 

























1. A two factor analysis, completely randomized design, consider 
SA fixed and T random. 
2. Polydimethylsiloxane. 
3. F Ratios: for SA use SA/SA x T; for T use T/EMS; for SA x T 




DUNCAN.' S NEW MULTIPLE RANGE TEST APPLIED TO TESTOSTERONE 
CONCENTRATIONS IN DISTILLED WATER BATHING 
PDS TESTOSTERONE CAPSULES 
p=2 p=3 p=4 p=5 p=6 p=7 p=8 
Ranked 
ritical Values, p<0.05 
p=9 
Code Means 23.9 25.0 25.7 26o4 26.8 27.1 27.4 27.9 
900-24 212 
900-12 138 74 
900-6 96 42 116 
450-24 96 0 42 116 
225-24 62 34 34 76 150 
450-12 53 9 43 43 85 159 
225-12 33 20 29 63 63 105 179 
450-6 32 1 21 30 64 64 106 180 
225-6 20 12 13 33 42 76 76 118 192 
-TABLE XVII 
ANALYSIS OF VARIANCE! OF TRITIUM CONCENTRATION IN· PERIPHERAL 
PLASMA OF INTACT MALE RABBITS CONTAINING 
SUBCUTANEOUS PDS2 TESTOSTERONE CAPSULES 
Experiment 2 
Source df SS ms F Ratio3 
Total (uncor.) 126 
Mean 1 17,327,929 
Surface Area (SA) 2 3,768,222 1,884,111 159.8* 
Time (T) 5 83,087 16,617 <l 
SA x T 10 117,903 11,790 <l 
Error 108 9,878,874 91,471 
11.0 
1. A two factor analysis, completely randomized design, consider 
SA fixed and T random. 
2. Polydimethylsiloxane 
3. F ratios: for SA use SA/SA x TJ for T use T/EMS; for SA x T 


























DUNCAN'S NEW MULTIPLE RANGE TEST AP~LIED TO TRITIUM CONCENTRATION IN PERIPHERAL PLASMA OF 
INTACT MALE RABBITS CONTAINING SUBCUTANEOUS PDS TESTOSTERONE CAPSULES: EXPERIMENT 4 
J2::2 :12=3 :12=4 12=5 12=6 :12=7 12=8 12=9 12=10 .12=1112=12 .12=13 12=14 .12=15 12=16 .12=17 12=18 .12=19 J2::20 J2::21 
Ranked 
Means ritical Values, p<0.05 
76 80 82 84 86 87 88 89 89 90 90 91 91 92 92 92 93 93 93 94 
797 
746 51 
741 5 56 
723 17 23 74 
690 33 51 56 107 
687 3 36 54 59 110 
661 26 29 62 80 85 136 
350 11 337 340 373 391 396 447 
347 3 314 340 343 376 394 399 450 
331 16 19 330 356 359 392 410 415 466 
307 24 40 43 354 380 383 416 434 439 490 
277 30 54 70 · 73 384 410 413 446 464 469 520 
269 8 38 62 78 81 392 418 421 454 472 477 528 
25~ 13 21 51 75 91 94 405 431 434 467 485 490 541 
252 4 17 25 55 79 95 98 409 437 438 471 489 494 545 
250 2 6 19 27 57 81 97 100 411 437 440 473 491 496 547 
196 54 56 60 73 81 111 135 151 154 465 491 494 427 545 550 601 
182 14 68 70 70 87 95 125 149 165 168 479 505 508 541 559 564 615 
181 1 15 69 69 88 88 96 126 150 156 179 480 506 509 542 560 565 616 
162 19 20 34 34 94 94 107 115 145 169 185 188 499 522 528 561 579 584 635 





ANALYSIS OF VARIANCE! OF PERIPHERAL PLASMA TRITIUM CONCENTRATION 
OF INTACT MALE RABBITS CONTAININ'G ~UBCUTANEOUS OR 
INTRAPERITONEAL 450 SQ. MM. PDS TESTOSTERONE 
IMPLANTS: EXPERIMENT 3 
Source df SS ms F Ratio 
Total ( cor. ) 59 556,476 
Between 1 5,153 5,153 <l 
Within 58 551,323 9,506 
1. One-way analysis of variance. 
2. Polydimethylsiloxane. 
TABLE XX 
ANALYSIS OF VARIANCE! OF PERIPHERAL PLASMA TRITIUM CONCENTRATION 
OF INTACT MALE RABBITS' CONTAINING SUBCUTANEOUS OR 
INTRAPERITONEAL ~o SQ. MM. pos2 TESTOSTERONE 
IMPLANTS: EXPERIMENT 3 
I . 
Source df SS ms F Ratio 
Total ( cor. ) 59 2,198,972 
Between 1 122,221 122,221 3.41 
Within 58 2,076,751 35,806 








ANALYSIS OF VARIANCE1 OF TOTAL DAILY SPERM 
PRODUCTION OF RABBITS: ,EXPERIMENT 4 
df SS ms 
20 208,729 
2 138,668 69,334 
18 70,062 3,892 





DUNCAN'S NEW MULTIPLE RANGE TEST APPLIED TO TOTAL DAILY 
SPERM PRODUCTION OF RABBITS: EXPERIMENT 4 
p=2 p=3 
Treatment Code Ranked Critical Values, p~0.05 
Means 69.56 73.1 
430 c Intact 214.9 
215 T Intact 123.5 91.4 
430 T Intact 16.1 107.4 198.3 
113 
Source 




ANALYSIS OF VARIANCE! OF PAIRED TESTIS 
WEIGHTS OF RABBITS: EXPERIMENT 4 
df SS ms 
20 100.5156 
2 73.5606 36.7803 
18 26.9550 1.50 
1. One-way analysis of variance. 
*P<0.01. 
TABLE XXIV 
DUNCAN'S NEW MULTIPLE RANGE TEST APPLIED TO PAIRED 





Ranked Critical Values~ P"-0.05 
Treatment Code Means 1.37 1.44 
430 C Intact 6.14 
215 T Intact 3.62 2.52 







I x T 
Error 
TABLE XXV 
ANALYSIS OF VARIANCE! OF SEX BEHAVIOR 
SCORES OF RABBITS: EXPERIMENT 4 
df SS ms 
41 732.61 
2 265.43 132.7 
1 107.52 107.5 
2 99.56 49.8 





l. A two factor analysis, completely randomized design, consider 
I fixed and T random. 
2. F ratios: for I use I/Ix T; for T use T/EMS; for Ix T use 
I x T/EMS. 
*P<0.01. 
TABLE XXVI 
DUNCAN'S NEW MULTIPLE RANGE TEST APPLIED TO SEX BEHAVIOR 
SCORES OF RABBITS: EXPERIMENT 4 
E::2 :e=3 12=4 :e=5 
Ranked 
Treatment Code Means Critical Values, P<0.05 
2.95 3.1 3.18 3.26 
430 T Intact 9.9 
430 T Cast. 9.8 .1 
430 c Intact 8.65 1.15 ·1.25 
215 T Intact 8.07 .58 1. 73 1.83 
215 T Cast. 6.03 2.04 2.62 3. 77 3.87 






ANALYSIS OF VARIANCE! OF TESTOSTERONE CONCENTRATION IN 
PERIPHERAL PLASMA OF MALE RABBITS: EXPERIMENT 4 
Source df SS ms F Ratio2 
Total (Cor.) 35 7416.97 
Treatment 5 2126.30 425.3 
Implant (I) 2 509.68 254.8 <l 
Testes (T) 1 86.18 86.2 <l 
I x T 2 1530.41 765.2 4.34 
Error 30 5290.70 176.4 
1. A two factor analysis, completely randomized design, consider 
I fixed and T random. 




DUNCAN'S NEW MULTIPLE RANGE TEST APPLIED TO TESTOSTERONE CONCENTRATION 
IN PERIPHERAL PLASMA OF MALE RABBITS : EXPERIMENT 4 
:e=2 :e=3 :e=4 :12=5 12=6 
Ranked Critical Values, P<0.05 
Treatment Code Means 15.66 16.48 16.9 17.3 17.6 
430 T Cast. 2.24 
430 C Intact 2.14 1.0 
215 T cast. 2.09 1.5 .50 
430 T Intact 1.66 5.8 4.80 4.3 
215 T Intact 1.45 7.9 6.9 6.4 2.1 




ANALYSIS _OF VA!UANCEl OF SEMINAL VESICLE WEIGHTS 
. OF RABBITS: · EXPERIMENT 4 
df SS ms 
Total (cor.) 41 1.3~4 
Implant. (I) 
Testes (T) 



















l. A two factor analysis, ·completely randomized design, consider 
I fixe~ and .. T random •.. 
2. F ratios: for I use I/I.x Ti for T use T/EMSi for I:x T use 




DUNCAN'S-NEW MULTIPLE RANGE,TEST APPLIED TO SEMINAL 
VESICLE WEIGHTS OF . RABBITS : EXPER.IMENT 4 
,E::2 12=3 .12=A 12=5 
Ranked Critical Values, P<0.05 
Treatment Code Means 150 158 162 166 
430 c Intact 508 
43.0 · T cast. 476 32 
430 T Intact 398 78 110 
21.S T cast. 358 40 118 150 
215-T Cast. 297 61 101 179 211 








I x T 
Error 
TABLE XXXI 
ANALYSIS OF VARIANCE! OF PROSTATE GLAND 
WEIGHTS OF RABBITS: EXPERIMENT 4 
df SS ms 
41 1,831.9 
2 145.3 72.7 
1 367.9 367.9 
2 829.7 414.9 






1. A two factor analysis, completely randomized design, consider 
I fixed and T random. 




DUNCAN'S NEW MULTIPLE RANGE TEST APPLIED TO PROSTATE 
GLAND WEIGHTS OF RABBITS: EXPERIMENT 4 
:e::2 12=3 :e=4 :e=5 
Ranked Critical Values, P<0.05 
Treatment Code Means 125.7 132.2 135.7 139.2 
430 C Intact 693 
430 T Cast. 572 121 
430 T Intact 510 183 62 
215 T Intact 458 235 114 52 
215 T Cast. 415 278 157 92 43 





ANALYSIS OF VARIANCE1 OF VESICULAR GLAND 
WEIGHTS OF RABBITS: EXPERIMENT 4 
119 
Source df SS ms F Ratio2 . 
Total (cor.) 41 3,902.6 
Implant (I) 2 735.2 367.6 <1 
Testes (T) 1 991.1 997.1 25.81* 
I x T 2 795.4 397.7 10.36* 
Error 36 1,308.9 38.4 
1. A two factor analysis; completely randomized design, consider 
I fixed and T random. 
2. F ratios: for I use I/ Ix T; for T use T/EMS; for Ix T/EMS. 
*P<0.005. 
TABLE XXXIV 
DUNCAN'S NEW MULTIPLE RANGE TEST APPLIED TO VESICULAR 
GLAND WEIGHTS OF RABBITS: EXPERIMENT 4 




Treatment Code Means 214 225 231 237 241 
430 C Intact 807 
430 T Intact 804 3 
430 T Cast. 778 29 26 
215 T Intact 762 45 42 16 
215 T Cast. 539 268 265 239 223 
430 C Cast. 129 678 675 649 633 410 
TABLE XXXV 
- ANALYSIS OF VARIANCE! OF BULBOURETHRAL GLAND 
WEIGHTS OF RABBITS: EXPERIMENT 4 
Source df SS ms 
Total (cor.) 41 1,755.8 
Implants (I) 2 275.5 137.8 
Testes (T) 1 295.7 295.7 
I x T 2. 322.1 161.l 
Error 36 862.5 24 
1. A two factor analysis, completely randomized design, 
I fixed and T random. 
2. F ratio: for I use I/I x T; for T use T/EMS; for Ix 










DUNCAN'S NEW MULTIPLE RANGE TEST APPLIED TO BULBOURETHRAL 
GLAND WEIGHTS OF RABBITS: EXPERIMENT 4 
p=2 :e=3 :e=4 :e=5 :e=6 
Ranked ritical Values, P<0.05~~-
Treatment Code Means 
619 177 18,2 187 190 
430 c Intact 622 
430 T Cast. 616 6 
430 T Intact. 608 14 8 
215 T Intact 527 95 89 81 
215 T cast. 424 198 192 184 103 





ANALYSIS OF VARIANCE! OF CITRIC ACID CONCENTRATION 
IN RABBIT SEMINAL PLASMA: . EXPERIMENT 4 
df SS . ms 
(cor.) 41 32 .• 7464 
Implant (I) 2 7.5412 7.54 
Testes (T) 1 5.9853 5.99 
I x T 2 9.0065 4.50 





l. A two factor analysis, completely randomized design, consider 
I fixed and T random. 




DUNCAN'S NEW MULTIPLE RANGE TEST APPLIED TO CITRIC ACip 
CONCENTRATION IN RABBIT SEMINAL PLASMA: EXPERIMENT 4. 
E:;:2 ;e=3 :e=4 ;e=5, 
Ranked Critical Values, P<Q.05 
Treatment Code Means 0.5815 0.611 0.628 0.644 
430 T cast. 2.11 
430 C Intact 1. 73 0.38 
215 T Intact 1.64 0.09 0.47 
430·T Intact 1.62 0.02 0.11 0.49 
215 T Cast. 0.62 1.00 1.02 1.11 1.49 






ANALYSIS OF VARIANCE! OF FRUCTOSE CONCENTRATION 
IN RABBIT SEMINAL PLASMA: EXPERIMENT 4 
122 
Source df SS ms F Ratio2 
Total · (cor.) 41 
Implants (I) 2 6.3317 3.1659 <l 
Testes (T) 1, 10.6304 10.6304 15.47* 
I x T 2 16.8905 8.4453 12.29* 
Error 36 24.744 0.6873 
1. A two factor .analysis; completely randomized design, consider 
I fixed and T random • 




DUNCAN'S NEW MULTIPLE RANGE TEST APPLIED TO FRUCTOSE 
CONCENTRATION IN RABBIT SEMINAL PLASMA: EXPERIMENT 4 
E::2 E=3 E=4 E=5 
Ranked Critical Values, P<0.05 
Treatment Code Means 0.905 0.952 0.978 1.00 
430 'I' Cast. 2.46 
215 T Intact 2.37 0.90 
430 c Intact 2.30 0.70 0.160 
430 T Intact 1. 74 0.56 0.630 0.72 
215 T Cast. 0.928 0.812 1.37 1.44 1.53 





ANALYSIS OF VARIANCE! OF TOTAL DAILY SPERM 
PRODUCTION IN MA'!'URE RABBITS: EXPERIMENT 4 
12.3 
Source df SS ms F Ratio2 
Total (cor.) 35 448,730 
Treatment 5 284,893 
Error 30 163,837 





DUNCAN'S NEW MULTIPLE RANGE TEST APPLIED TO TOTAL DAILY 
SPERM PRODUCTION IN MATURE RABBITS: EXPERIMENT 5 
E=2 E=3 ]2=4 ]2=5 
Ranked Critical Values, P<0.05 
Treatment Code Means 35.5 37.3 38.3 39.3 
400 C 210 
100 T 198 12 
200 T 154 44 56 
400 T 34 120 164 176 
1600 T 7 27 147 191 203 






ANALYSIS OF VARIANCEl OF PAIRED TESTIS WEIGHTS 
OF MATURE RABBITS: EXPERIMENT 5 
Source df SS ms F Ratio 
Total ( cor. ) 35 159.83 
Treatment 5 120.93 
Error 30 38.9 





DUNCAN'S NEW MULTIPLE RANGE TEST APPLIED TO PAIRED TESTIS 
WEIGHTS OF MATURE RABBITS: EXPERIMENT 5 




Critical Values, P<0.05-_--~ Treatment Code Means 
0.55 0.53 0.59 0.61 0.62 
400 C 4.9 
100 T 4.9 0.0 
200 T 4.5 0.4 0.4 
400 T 1.9 2.6 3.0 3.0 
1600 T 1.0 0.9 3.5 3.9 3.9 
800 T .7 0.3 1.2 2.8 4.2 4.2 
124 
TABLE XLV 
ANALYSIS OF VARIANCE! OF SEMINAL VESICLE WEIGHTS 
OF MATURE RABBITS: EXPERIMENT 5 
Source df SS 
Total ( cor • ) 35 3,416 
Treatment 5 2,419 
Error 30 987 








DUNCAN'S NEW MULTIPLE RANGE TEST APPLIED TO SEMINAL VESICLE 
WEIGHTS OF MATURE RABBITS: EXPERIMENT 5 
E=2 E=3 E=4 :12=5 12=6 
Ranked ritical Values, P<0.05~~-
Treatment Code Means 
87 90 94 96 98 
1600 T 1,015 
200 T 389 626.5 
800 T 375 14.0 62.05 
400 C 312 62.4 76.4 702.9 
400 T 311 0.8 63.2 77.2 693.7 
100 T 306 5.0 5.8 68.2 82.2 709 
125 
TABLE XLVII 
ANALYSIS OF VARIANCE1 OF VESICULAR GLAND WEIGHTS 
OF MATURE RABBITS: EXPERIMENT 5 
126 
Source df SS ms F Ratio 
Total ( cor. ) 35 1,755,095 
Treatment 5 569,264 
Error 30 1,185,831 





DUNCAN'S NEW MULTIPLE RANGE TEST APPLIED TO VESICULAR GLAND 
WEIGHTS OF MATURE RABBITS: EXPERIMENT 5 
E=2 E=3 E=4 E=5 E=6 
Ranked ritical Values, P<0.05~~-Treatment Code Means 235 247 253 260 264 
1600 T 955 
100 T 788 167 
800 T 710 79 245 
200 T 652.0 58 136 303 
400 C 642 10 68 147 313 






ANALYSIS OF VARIANCE! OF PROSTATE GLAND WEIGHTS 
OF INTACT MALE RABBITS: EXPERIMENT 5 
df SS ms 
35 1,520,000 
5 227,000 45,400 
30 1,293,000 43,100 
1. One-way analysis of variance. 
TABLE L 
ANALYSIS OF VARIANCE1 OF BULBOURETHRAL GLAND 
WEIGHTS OF INTACT RABBITS: EXPERIMENT 5 
Source df SS ms 
Total ( cor. ) 35 2,531,662 
Treatment 5 566,840 113 ,368 
Error 30 1,964,822 65,494 
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